Biotech China 2014

View Profile


Speaking/Presenting-Abstract/Poster at Mtg

Topic Authors / presenters Event name Event date
1. What you need to know about antiarrhythmic and anticoagulant medications Boston Scientific Fellows Symposium, Boston, MA June, 2013
2. Acute and Chronic Pharmacologic therapy for VT/VF VT/VF Summit at Heart Rhythm Society Scientific Sessions, Denver, CO May, 2013
3. Antiarrhythmic Drugs in the future Stanford Biotech Symposium, Denver, CO May, 2013
4. Oral Anticoagulation for Stroke Prevention in Atrial fibrillation Scientific Symposium at American College of Cardiology Meeting. San Francisco, CA, March, 2013
5. Deadly Rhythm” Book signing at Authors and Experts Dinner Program Population Health Symposium, Jefferson Medical College, Philadelphia, PA, March, 2013
6. Current uses and limitations of the Novel oral anticoagulants in AF Boston AF Symposium, Boston, MA January, 2013
7. Oral anticoagulation during catheter ablation of AF Symposium. AF Ablation Innovations, New York, NY, December, 2012
8. Cardiovascular Assessment in Drug Development CSRS Annual Meeting, FDA Headquarters, White Oak, MD, December, 2012
9. Initiating therapy with novel oral anticoagulation in AF Product Theatre at American Heart Association Meeting, Los Angeles, CA November, 2012
10. An update on the new anticoagulant for AF stroke prevention Symposium. Robert Wood Johnson School of Medicine, Princeton, NJ, October, 2012
11. Pharmacological Management of Atrial and Ventricular Arrhythmias ACC Symposium. Washington, DC September, 2012
12. Cardiovascular Safety in Drug development Grand Rounds, St. Christopher’s Children’s Hospital, Philadelphia, PA September, 2012
13. How to establish Risk Boundaries for hypertension trials CSRC Think Tank. FDA. White Oak, MD July, 2012
14. The New Anti-coagulants: which drug for which patient? Texas Heart Institute Cardiology Grand Rounds. Houston, TX. June, 2012
15. Antiarrhythmic Drug Therapy for AF EP101 for incoming Fellows. Boston Scientific Symposium. Boston, MA June, 2012
16. New Antiarrhythmic Pharmacology Stanford Biotechnology Symposium. Boston, MA May, 2012
17. Management of AF in patients with hypertension National Scientific Sessions. American Society of Hypertension. New York, NY May, 2012
18. What’s new in the management of ventricular Tachyarrhythmias? Jeresaty Symposium. Hartford, CN. May, 2012
19. AF ablation is not a first line therapy Debate Session. Heart Rhythm Society Scientific Sessions. Boston, MA May, 2012
20. Cutting Edge Therapies in AF. Satellite Symposium. Heart Rhythm Society Scientific Sessions Boston, MA May, 2012
21. Cardiac Safety of Non-Cardiac Drugs. Symposium St. Joseph’s Hospital, Reading, PA. April, 2012
22. DIA Cardiac Safety/Diabetes Meeting. Co-chair. Washington, DC April, 2012
23. Malpractice Reform Medical-Legal Conference: Malpractice Reform. Lankenau Medical Center, Wynnewood, PA April, 2012
24. Meet the Experts Symposium: What are the alternatives to Warfarin for Patients with AF? American College of Cardiology Scientific Sessions, Chicago, IL March, 2012
25. Clinical Focus on AF. Chair of Satellite Symposium, American College of Cardiology Scientific Sessions, Chicago, IL March, 2012
26. AF Management Update Cardiology Grand Rounds, Columbia University, New York, NY March, 2012
27. New Strategies for Stroke Prevention in Patients with AF Symposium St. Mary, Langhorne, PA February, 2012
28. Authors and Experts Book signing Population Health Symposium. Jefferson Medical College, Philadelphia, PA February, 2012
29. AF Management: Medical Management Medical Grand Rounds. Lahey Clinic, Burlington, MA. January, 2012
30. Current Status of Antiarrhythmic Drugs for AF Boston AF Symposium. Boston, MA January, 2012
31. Cardiac Safety for Non-cardiac Drugs. Williamsburg Symposium. Baylor University, Williamsburg, VA December, 2011
32. New Drugs for Treatment of Atrial Fibrillation Boston Scientific Symposium. San Francisco, CA December, 2011
33. Atrial Fibrillation Management Medical Grand Rounds, Community Medical Center, Scranton, PA November, 2011
34. Celivarone for Reduction of ICD Shocks and Seath in Patients with Implantable Defibrillators. Late-Breaking Clinical Trials American Heart Association Scientific Sessions, Orlando, FL November, 2011
35. Anti-Arrhythmic Drugs and Anti-Coagulants for Atrial Fibrillation American Heart Association Annual Scientific Sessions. Symposium. Orlando, FL November, 2011
36. What the Internist Needs to Know About Atrial Fibrillation Management Grand Rounds. Cooper University Medical Center. Camden, NJ November, 2011
37. New Developments in Atrial Fibrillation Management Primes Symposium. Boston, MA. October, 2011
38. New Anti-Arrhythmic Drugs PA. ACC Chapter Fellows-in-Training Conference. Philadelphia, PA. October, 2011
39. Comprehensive Clinical Management of Atrial Fibrillation Vassar Brothers Medical Center Symposium. Dutchess County, New York. October, 2011
40. Atrial Fibrillation: Clinical Management Scientific Symposium, Sharpe Foundation, Newport Beach, CA. September, 2011
41. Update: Catheter Ablation for AF American/Spanish Cardiology Societies-Joint Meeting. Washington, D.C. September, 2011
42. Are These Novel Antiarrhythmic Drugs on Horizon for Sudden Death? Heart Failure Society of America, Scientific Sessions. Boston, MA September, 2011
43. New Concepts in Management of Atrial Fibrillation Cardiology Grand Rounds, Boston University, Boston, MA September, 2011
44. Diagnosis and Treatment of AF Pro-Med Lecture. New York, NY. June, 2011
45. Atrial Fibrillation: New Management Concepts Cardiology Conference, Winchester General Hospital, VA June, 2011
46. Challenging Cases of AF. Satellite Symposium, Heart Rhythm Society, San Francisco, CA May, 2011
47. Antiarrhythmic Drugs for Ventricular Arrhythmias Symposium at Heart Rhythm Society National Scientific Sessions, San Francisco, CA. May, 2011
48. The Contemporary Management of Atrial Fibrillation Cardiology Grand Rounds, Sentara General Hospital, Norfolk, VA. May, 2011
49. Measuring and Improving Outcomes in AF ACC Symposium, National Scientific Sessions of the American College of Cardiology, New Orleans, LA April, 2011
50. Stroke Prevention in AF. Cardiology Grand Rounds, St. Luke’s Medical Center Bethlehem, PA April, 2011
51. Chair Medical-Legal Symposium. Philadelphia, PA April, 2011
52. Contemporary Management of Atrial Fibrillation Cardiology Grand Rounds, Texas Heart/ St. Luke’s, Houston, TX. April, 2011
53. Atrial Fibrillation: Improving Clinical Outcomes Medical Grand Rounds, Drexel University/ Hahnemann Hospital, Philadelphia, PA January, 2011
54. New Antiarrhythmic Drugs for AF: What’s after Dronedarone? Boston AF Symposium, Boston, MA January, 2011
55. Preventing Stroke in AF-Why Anticoagulation is about to get interesting The Williamsburg Conference (Baylor University), Williamsburg, VA December, 2010
56. Aspects of Atrial Fibrillation diagnosis and management The Robinson Lecture, University of Massachusetts, Worcester, MA, December, 2010
57. Prescription Omega-3-Fatty Acids for the Prevention of Paroxymal AF. Late-breaking clinical trials, AHA International Scientific Sessions, Chicago, IL November, 2010
58. Practical Management of AF: A Case-based approval Chair Satellite Symposium, AHA International Scientific Session, Chicago, IL, November, 2010
59. The Myth of Antiarrhythmic Medications: The Old and New. St. Francis Hospital Symposium, Long Island, NY October, 2010
60. Management of AF Grand Rounds, New Jersey University Medical Center, Stratford, NJ October, 2010
61. Atrial Fibrillation: Improving prevention and treatment Grand Rounds, Franklin Hospital, Baltimore MD September, 2010
62. Atrial Fibrillation: Improving prevention and treatment Grand Rounds, East Orange VA Medical Center, East Orange, NJ June, 2010
63. Recent Advances in AF-where do we go from here Satellite Symposium Choier, Heart Rhythm Society Scientific Sessions, Denver, CO May, 2010
64. AF in the hypertensive patient American Society of Hypertension Scientific Session, New York City, NY May, 2010
65. Contemporary AF Management Cardiology Grand Rounds, SUNY, Stoney Brook, New York May, 2010
66. Role of registries in outcomes-based Research Core Curriculum, Heart Rhythm Society Scientific Sessions, Denver, CO May, 2010
67. Why are non-cardiac drugs killing people or are they? Teresaty Symposium, Hartford, CN, May, 2010
68. Modern Management and advances in AF Management Cardiology Grand Rounds UCSF, San Francisco April, 2010
69. Atrial Fibrillation: Improving prevention and treatment options Jersey City Medical Center Grand Rounds, Jersey City, NJ March, 2010
70. Atrial Fibrillation and Stroke Prevention UMDNJ Grand Rounds, Newark, NJ March, 2010
71. Has the balance shifted in the Rate vs Rhythm control debate? Satellite Symposium, ACC, Atlanta, GA, March, 2010
72. Initiating Dronedarone in patients receiving Amiodarone Oral presentation, ACC Scientific Sessions, Atlanta, GA March, 2010
73. Atrial Fibrillation Management: Why is it complex? Temple University Grand Rounds, Philadelphia, PA, February, 2010
74. The promise and peril of new drug development: What is the path forward? Boston AF Symposium, Boston, MA, January, 2010
75. AF Management: Why is it so hard? Williamsburg ACC Symposium. Williamsburg, VA. December, 2009
76. CREATE Scientific Meetings. Co-Chair. Paris, France December, 2009
77. Atrial Fibrillation Forum Satellite Meeting at American Heart Association Scientific Session, Orlando, FL November, 2009
78. Contemporary Management of atrial fibrillation New Jersey Chapter of ACC. Holmdel, NJ October, 2009
79. Contemporary Management of atrial fibrillation Beth Israel Hospital Symposium. Princeton, NJ September, 2009
80. AF Summit Heart Rhythm Society Scientific Sessions. Heart Rhythm Society. Boston, Mass May, 2009
81. Adjevant Antiarrhythmic Drug Therapy after Ablation. Symposium. Heart Rhythm Society Scientific Sessions, Boston, Mass May, 2009
82. Course Director: Arrhythmic Management for the Practicing Clinician American College of Cardiology Program. Philadelphia, PA April, 2009
83. Course Co-Director: Cardiac Safety Symposium Drug Information Association, Washington, DC April, 2009
84. Antiarrhythmic Drugs: Targeting the re-modeled Myocardium Scientific Sessions of American College of Cardiology, Orlando, FL March, 2009
85. Differences in clinical outcomes with rhythm- and-rate-control therapies for atrial fibrillation Camm J, Breithardt G, Le Heuzey J-Y, Crijns H, Dorian P, Kowey P, Prystowasky EN, Schwartz PJ, Torp-Pedersen C, Weintraub W. RecordAF registry. Circulation January, 2009
86. Comparison of QTinno, a Fully Automated Quantitative ECG Analysis Program, to Computer-Assisted Samuel George, Thor Gussak, Bosko Bojovic, Branislav Vajdic, Steven Francom, Peter Kowey ACC January, 2009
87. Brugada Syndrome Unmasked by Fever-Is There Always a Need for Implantable Cardiac Defibrillator Placement? Jihong Guo, Yaxun Sun, Bortolo Martini, Tarun Mathur, Gan-Xin Yan, Peter R Kowey, Li Zhang Heart Rhythm January, 2009
88. Athena: Landmark AF trial and its implications Boston AF Symposium, Boston, Mass January, 2009
89. How to evaluate New Therapies in AF Cardiology Grand Rounds, University of Rochester, Rochester, NY December, 2008
90. New Treatment for AF Chair, Satellite Symposium, American Heart Association Scientific Session, New Orleans, LA November, 2008
91. Challenging Arrhythmia Cases Symposium, American Heart Association Scientific Session, New Orleans, LA November, 2008
92. Anticoagulation Strategies in AF Co-Chair, Satellite Symposium, American Heart Association Scientific Sessions, New Orleans, LA November, 2008
93. Unconventional Therapies of AF Sierra Heart Failure Institute Symposium. Squaw Creek, CA October, 2008
94. Hot Topics in Cardiac Safety. CSRC-HESI Annual Meeting. Bethesda, MD October, 2008
95. Regulatory issues in the development of new agents for atrial fibrillation Grand Rounds, FDA, White Oak, MD September, 2008
96. What have we learned from Phase III Antiarrhythmic Drug trials Symposium. Washington, DC, September, 2008
97. Issues in AF Management PRIMED Symposium. New York, NY July, 2008
98. Selecting clinical outcomes in AF trials. Symposium, Boston, MA, June, 2008
99. Complex Clinical Trials in AF Cardiology Grand Rounds, Beth Israel Medical Center, Boston, MA June, 2008
100. Is Ablation a first time therapy in AF Symposium, Boston, MA June, 2008
101. Drug therapy for AF Mini-course. Heart Rhythm Society Scientific Sessions, San Francisco, CA May, 2008
102. Disease-specific therapy for AF Satellite Symposium, Heart Rhythm Society Scientific Sessions, San Francisco, CA, May, 2008
103. Evolving indications for device implantation Symposium, University of Pennsylvania, Philadelphia, PA May, 2008
104. New management strategies in AF Symposium, Lehigh Valley Medical Center, Bethlehem, PA May, 2008
105. Indications for CRT and ICD. Jeresoty Symposium, Hartford, CN April, 2008
106. AF Management in 2008 Cardiology Grand Rounds, Eisenhower Medical Center, Rancho Mirage, CA March, 2008
107. AF in the Elderly Symposium at American College of Cardiology Scientific Sessions, Chicago, IL March, 2008
108. New Agents and Unconventional Approaches in AF Satellite Symposium, American College of Scientific Sessions, Chicago, IL, March, 2008
109. Clinical Trials in AF: what are the end points? Temple University Cardiology Grand Rounds, Philadelphia, PA March, 2008
110. AHA abstract 11098 “Profile of patients” Peter Kowey, J.Y. Le Heuzey. AHA Scientific Sessions January, 2008
111. TWA abstract No. 11287 Peter Kowey, Gan-Xin Yan, Donglin Guo AHA Scientific Sessions January, 2008
112. Comparative Hemodynamic Effects of PM101 Michael R. Gralinski, Raymond J. Lipicky, Peter Kowey, Warren Cooper, Bill W. Massey, Daniel Cushing Novel Formulation of Amiodarone, and Cordarone IV in Anesthetized Dogs. AAPS January, 2008
113. Increased Late Atrial Myocetes of Left Ventricular Hypertrophy Rabbits and its Role Donglin Guo, Zhen Jiao, Binu Malhota, Chinmay Patel, Peter R Kowey, Gan-Xin Yan Genesis of Atrial Early Afterdepolarization. Circulation January, 2008
114. Discordant T Wave and Mechanical Alternans in Left Ventricular Hypertrophy Donglin Guo, Ying Wu, Tengxian Liu Role of Late Sodium Current. Circulation January, 2008
115. Increased late Ina in left atrial myocytes of LVH rabbits and its role in genesis of atrial early afterdepolarizations Peter Kowey, Gan-Xin Yan, Donglin Guo AHA Scientific Sessions January, 2008
116. Profile of Patients According to Chosen Therapeutic Strategy Jean-Yves Le Heuzey, Gunter Breithardt, John Camm, Harry Crijns, Paul Dorian, Peter Kowey, et al. RecordAF Global Registry on Atrial Fibrillation Management. Circulation January, 2008
117. New Modalities in AF Management Satellite Symposium at American Heart Association National Meeting, Orlando, FL November, 2007
118. Modern Day Treatment of AF Medical Grand Rounds, Monmouth Hospital, NJ November, 2007
119. A Review of the Medical Management of AF Fairfax Hospital Symposium, Fairfax, VA, November, 2007
120. Why is AF Management so hard? Community Hospital Symposium, Toms River, NJ November, 2007
121. Vernakalant for Acute termination of AF after Cardiac Surgery Trial result presentation. Scientific Program of American Heart Association Meeting, Orlando, FL November, 2007
122. New Anticoagulants for Atrial Fibrillation Co-Chair, Satellite Symposium at American Heart Association Meetings, Orlando, FL November, 2007
123. Acute Termination of Atrial Arrhythmias National Scientific Session, Emergency Medicine Physicians. Seattle, Washington, October, 2007
124. Clinical trials of medical treatment of ischemic heart disease Vascular Biology Working Group Symposium, New York, NY October, 2007
125. Medical Management of Atrial Fibrillation Cardiology Grand Rounds, Eisenhower Medical Center, Palm Desert, CA October, 2007
126. Medical Management of Atrial Fibrillation Washington Hospital Center Symposium. Washington, DC, September, 2007
127. Atrial Fibrillation Review Primed Symposium. West Chester, NY September, 2007
128. Role of Late INa in the genesis of cardiac arrhythmias Vascular Biology Working Group Symposium. Dallas, TX, July, 2007
129. Atrial Fibrillation Review Primed Symposium. Philadelphia, PA June, 2007
130. Atrial Fibrillation Ablation Guidelines Commentator, Atrial Fibrillation Summit at Heart Rhythm Society Meetings. Denver, CO, May, 2007
131. Cardiac safety of non-cardiac drugs: focus on the QT interval Cardiology Grand Rounds, Columbia University. New York, NY, May, 2007
132. Celiverone. Data from first Randomizes clinical efficacy Trial Heart Rhythm Society Meetings. Denver, CO May, 2007
133. Clinical trial design in Electrophysiology Heart Rhythm Society Meetings. Denver, CO May, 2007
134. Cardiac Safety in treating OAB Symposium American Geriatric Society. Seattle, WA, May, 2007
135. Issues in Cardiac Safety: The Electrocardiogram Co-chair, Drug Information Association Conference. Washington, DC April, 2007
136. Pharmacology of Arrhythmia Symposium American College of Cardiology. New Orleans, LA, March, 2007
137. Practical Aspects of Arrhythmic Management ACC Symposium. Snowshoe, West Virginia February, 2007
138. Ablation vs. Drug Therapy for Atrial Fibrillation. Medtronic Symposium. Phoenix, AZ, February, 2007
139. New and investigational Antiarrhythmic Drugs. Boston Atrial Fibrillation Symposium. Boston, MA January, 2007
140. How to manage post-op AF 35th Interpretation and Treatment of Cardiac Arrhythmias, (Chair). Philadelphia, PA December, 2006
141. New antiarrhythmic agents for treatment of atrial fibrillation Satellite Symposium, Scientific Sessions of American Heart Association. Chicago, IL November, 2006
142. Why is it hard to treat AF UMDNJ Symposium. Newark, NJ, October, 2006
143. How to manage AF PRIMED Symposium. Rahway, NJ October, 2006
144. Cardiac safety on non-cardiac drugs: Cardiac repolarization CREATE Symposium. Paris, France, October, 2006
145. New techniques for outpatient monitoring Cardiology Grand Rounds, Penn State Medical Center. Hershey, PA October, 2006
146. Atrial fibrillation. Why is it so hard to treat? Santa Fe Colloquium. Santa Fe, New Mexico September, 2006
147. Guiding the safety of non-cardiac drugs in the regulatory process American College of Cardiology Foundation Industry Forum. Washington, DC, June, 2006
148. Challenges and practical aspects of assessing clinical QT prolongation/proarrhythmic risk and implications for the clinical pathway Drug Information Association Meeting. Washington, DC May, 2006
149. Non-conventional therapies for AF Satellite Symposium. Heart Rhythm Society Scientific Sessions. Boston, MA, May, 2006
150. Biventricular pacing and AVN ablation controversies in devices Heart Rhythm Society Scientific Sessions. Boston, MA May, 2006
151. New and investigational drug approaches to AF Hartford Heart Rhythm Symposium. Hartford, CT April, 2006
152. Cardiac safety of non-cardiac drugs Jeresaty Symposium. Hartford, CT April, 2006
153. Novel and emerging ventricular antiarrhythmic drugs on the horizon Symposium, American College of Cardiology Scientific Sessions. Atlanta, GA, March, 2006
154. Rate vs. rhythm control revealed: Controversies in the management of atrial fibrillation Satellite Symposium, American College of Cardiology Scientific Sessions. Atlanta, GA, March, 2006
155. Drugs for ablation of atrial fibrillation Medtronic Symposium. Scottsdale, AZ February, 2006
156. New antiarrhythmic drugs for AF Boston AF Symposium. Boston, MA January, 2006
157. Unintended cardiac adverse effects of non-cardiac drugs The Arthur Richter Memorial Lecture. Indianapolis, IN December, 2005
158. Amiodarone: Perfect drug, perfect storm American Heart Association Scientific Sessions, Dallas, TX, November, 2005
159. Unconventional drugs for AF suppression Satellite Symposium. American Heart Association Scientific Sessions, Dallas, TX, November, 2005
160. New antiarrhythmic drugs Satellite Symposium. American Heart Association Scientific Sessions, Dallas, TX November, 2005
161. Controversies in AF management Good Samaritan Hospital Symposium, Los Angeles, CA, October, 2005
162. Aspects of AF management. Symposium, UMDNJ. Short Hills, NJ October, 2005
163. Rate-control versus rhythm control for atrial fibrillation Cleveland Clinic Symposium. Cleveland, OH September, 2005
164. Management of atrial fibrillation and the pharmacology of antiarrhythmic drugs National American College of Cardiology Board Review Course. Dallas, TX, September, 2005
165. Drug versus ablation therapy for AF. Debate. Medtronic Symposium. San Francisco, CA July, 2005
166. What have recent clinical trails taught us about rhythm management? Ramaswamy Memorial Lectureship. St. Elizabeth’s Hospital. Brighton, MA, June, 2005
167. Sudden death prevention Core curriculum, Heart Rhythm Society Scientific Session. New Orleans, LA, May, 2005
168. New antiarrhythmic drugs for AF: Will they improve the outcome of rhythm control Clinical Tutorial, Heart Rhythm Society Scientific Session. New Orleans, LA, May, 2005
169. Multi-channel drug treatment of atrial arrhythmic Satellite Symposium, Heart Rhythm Society Scientific Session. New Orleans, LA May, 2005
170. Pharmacologic therapy of atrial fibrillation Cleveland Clinic Symposium. Cleveland, OH April, 2005
171. Pharmacologic therapy of atrial fibrillation Cardiology Grand Rounds, Mayo Clinic. Rochester, MN April, 2005
172. Pharmacologic therapy of atrial fibrillation Medical Grand Rounds, Graduate Hospital. Philadelphia, PA April, 2005
173. Cardiac safety of non-cardiac drugs: EKG Guidance Co-chair, Drug Information Association Symposium. Bethesda, MD, April, 2005
174. Drug therapy for atrial fibrillation Structured Session National Scientific Session, American College of Cardiology. Orlando, FL March, 2005
175. New strategies for anticoagulation for patients with atrial fibrillation Cardiology Grand Rounds, California Pacific Medical Center. San Francisco, CA March, 2005
176. Clinical antiarrythmic drug trials Cardiology Grand Rounds, Medical College of Virginia, Richmond, Virginia March, 2005
177. New pharmacology for arrhythmia management Satellite Symposium, National Scientific Session. American College of Cardiology. Orlando, FL March, 2005
178. Drug versus ablation for AF Medtronic National Symposium. Orlando, FL February, 2005
179. Optimal management of post-MI Patients with and without heart failure. Symposium chair. New York, NY January, 2005
180. Introduction to atrial fibrillation. Symposium, American College of Cardiology and Main Line Health Heart Center. Philadelphia, PA, December, 2004
181. Drug prophylaxis: Can it be done? Symposium, American College of Cardiology and Main Line Health Heart Center. Philadelphia, PA December, 2004
182. Drugs in arrhythmia management: Summary of clinical trials Special Symposium. American Heart Association Scientific Sessions. New Orleans, LA November, 2004
183. Drug Treatment of AF Cardiology Grand Rounds, Albert Einstein Medical Center. Philadelphia, PA October, 2004
184. Regulatory issues in drug development New Technology Retreat. Chicago, IL October, 2004
185. New strategies in management of atrial fibrillation Symposium, Columbia University, New York, NY October, 2004
186. Pharmacology of antiarrhythmic drugs Cardiology Grand Rounds, Hershey Medical Center, Penn State University. Hershey, PA October, 2004
187. Management of patients with syncope Lake Tahoe Symposium. Squaw Creek, CA, October, 2004
188. Pharmacologic treatment of AF. Cardiology Grand Rounds, Presbyterian Hospital – University of Pennsylvania. Philadelphia, PA September, 2004
189. The INVEST trial: Clinical evidence in antihypertensive management Medical Grand Rounds, Methodist Hospital. Philadelphia, PA July, 2004
190. Antiarrhythmic drug treatment of AF. Symposium, Baptist Hospital. Memphis, TN June, 2004
191. New therapies for stroke prevention in AF Symposium. Baltimore, MD June, 2004
192. New anti-thrombotics in management of AF Cardiology Grand Rounds, Boston University. Boston, MA, May, 2004
193. Practical issues in arrhythmia management Symposium, Mercy Heart Institute. Sacramento, CA May, 2004
194. New class III antiarrhythmic drugs Clinical tutorial, Heart Rhythm Society Scientific Sessions. San Francisco, CA, May, 2004
195. Algorithms for prevention and treatment of sudden death after myocardial infarction. Satellite symposium, Heart Rhythm Society Scientific Sessions. San Francisco, CA, May, 2004
196. INVEST: New trials in antiarrhythmic therapy Symposium. Princeton, NJ, May, 2004
197. Antithrombotic therapy for AF patients Medical Grand Rounds, St. Mary Hospital. Langhorne, PA, April, 2004
198. Anticoagulation strategies for patients with AF. Jeresaty Symposium. Hartford, CT, April, 2004
199. AF and stroke Webcast, George Washington University. Washington, DC April, 2004
200. The long QT syndrome Symposium, California Heart Association. Carmel, CA April, 2004
201. New strategies in stroke prevention in AF Medical Grand Rounds, Frankford Hospital. Philadelphia, PA, March, 2004
202. A discussion of INVEST. ACC Conversation with Experts. American College of Cardiology Scientific Sessions. New Orleans, LA, March, 2004
203. Practical issues in antiarrhythmic drug management Symposium, American College of Cardiology Scientific Sessions. New Orleans, LA March, 2004
204. Thiazide diuretics are (are not) proarrhythmia Debate, Heart Rhythm Society. New Orleans, LA, March, 2004
205. QT prolongation with drugs to treat urological disorders Symposium. Orlando, Florida February, 2004
206. Regulatory issues in new drug development Symposium, Christiana Hospital. Newark, DE February, 2004
207. Antiarrhythmic drug therapy Cardiology Grand Rounds, Beth Israel Hospital. New York, NY, February, 2004
208. New anticoagulation strategies. Symposium. Miami, FL, February, 2004
209. AF treatment and stroke prevention Symposium, Vascular Biology Working Group. Philadelphia, PA December, 2003
210. Losartan and CV and renal outcomes Poster presentation, American Heart Association, Scientific Sessions. Orlando, FL November, 2003
211. AF: The public health perspective Satellite Symposium, Vascular Biology Working Group. Orlando, FL November, 2003
212. Prognostic significance of ventricular arrhythmia ACCF Satellite Symposium. Santa Fe, NM October, 2003
213. Stroke prevention and atrial fibrillation Columbia University Symposium. New York, NY October, 2003
214. Significance of QT prolongation with urologic drugs Symposium. Dallas, TX October, 2003
215. Atrial fibrillation Medical Grand Rounds, Graduate Hospital. Philadelphia, PA September, 2003
216. Pharmacology of antiarrhythmic drugs and management of AF ACCF National Board Review Course. Chicago, IL September, 2003
217. Clinical trials debates North American Society of Pacing and Electrophysiology Scientific Sessions. Washington, DC May, 2003
218. Tedisamil for rapid conversion of atrial arrhythmias Results of a multi-center trial. Late-breaking clinical trials session. North American Society of Pacing and Electrophysiology Scientific Sessions. Washington, DC May, 2003
219. QT interval measurement Barnett International Symposium. Philadelphia, PA May, 2003
220. AF: trials and management. Symposium, St. Luke’s Hospital. Bethlehem, PA March, 2003
221. Management of ventricular arrhythmia. Chair, Luncheon Panel. American College of Cardiology Scientific Sessions. Chicago, IL March, 2003
222. Overview of AF Trials: What is the state of the Art. Closed Symposium, American College of Cardiology Scientific Sessions. Chicago, IL March, 2003
223. Clinical Trials and Rhythm Management American College of Cardiology at Snowshoe. West Virginia February, 2003
224. Antiarrhythmic drug therapy of AF. Fellows Mentoring Meeting Futura. Houston, Texas January, 2003
225. Regulatory issues regarding cardiac repolarization and the QT interval. Panelist Drug Information Association, Rockville, MD, January, 2003
226. Late-breaking clinical trials. Chair & Commentator, AHA Scientific Sessions. Chicago, Illinois November, 2002
227. Case studies in AF. Dinner program AHA Scientific Session. Chicago, Illinois November, 2002
228. Management of atrial fibrillation Symposium, Community Medical Center, Toms River, New Jersey, October, 2002
229. Drug therapy for AF Cardiology lecture, Bridgeport Hospital. Bridgeport, Connecticut October, 2002
230. Stroke prevention and AF Symposium Chairman. Main Line Health Heart Center, Philadelphia, Pennsylvania October, 2002
231. Treatment of life-threatening ventricular arrhythmia Emergency Medicine Grand Rounds, St. Luke’s Medical Center, Bethlehem, Pennsylvania, October, 2002
232. Modern treatment for AF: Non-drug approaches Cardiology Conference, Hoag Hospital, Newport Beach, California September, 2002
233. Management of atrial fibrillation Medical Grand Rounds, Methodist Hospital, Philadelphia, Pennsylvania August, 2002
234. QT effects of cardiac and non-cardiac drugs: Regulatory issues. Core curriculum, North American Society of Pacing and Electrophysiology 23rd Annual Scientific Sessions, San Diego, California May, 2002
235. Contemporary management of AF American Heart Association, Symposium. Long Island, New York May, 2002
236. What clinical trials have taught us about managing patients with ventricular arrhythmias Jeresaty Symposium. Hartford, Connecticut May, 2002
237. New and developing antiarrhythmic drugs Cardiology Update, Presbyterian-University of Pennsylvania Medical Center. Absecon, New Jersey April, 2002
238. New ACLS Guidelines and evidence-based medicine Cardiology Grand Rounds, Mount Sinai Medical Center. Miami, Florida April, 2002
239. Pharmacological therapy of atrial fibrillation American College of Cardiology 51st Annual Scientific Sessions, Abstract Chair. Atlanta, Georgia March, 2002
240. Guidelines for emergency therapy of life-threatening arrhythmias Cardiothoracic Surgery Grand Rounds, Presbyterian-University of Pennsylvania Medical Grand Rounds. Philadelphia, Pennsylvania March, 2002
241. Arrhythmia management for the practicing clinician Columbia University symposium, Co-Chair. New York, New York February, 2002
242. Assorted arrhythmia topics Fellows Mentoring Course, Faculty. Houston, Texas February, 2002
243. Treatment of highly malignant ventricular arrhythmias Medical Grand Rounds, Robert Wood Johnson Medical School. New Brunswick, New Jersey December, 2001
244. Arrhythmia management for the practicing physician Main Line Health Heart Center symposium, Program Co-Chair. Philadelphia, Pennsylvania, November, 2001
245. Strategies for the clinical development of agents for acute AF termination Symposium, Hungarian Academy of Science. Budapest, Hungary November, 2001
246. Prevention of post-operative atrial arrhythmias (COPPA-II). Late-breaking clinical trials session, National Scientific Sessions, American Heart Association, Anaheim, California November, 2001
247. Contemporary management of ventricular arrhythmias Cardiology Grand Rounds, Stamford Hospital. Stamford, Connecticut October, 2001
248. Antiarrhythmic drug therapy Jefferson Medical College Cardiology Board Review Course. Philadelphia, Pennsylvania October, 2001
249. Pharmacologic therapy of cardiac arrhythmias American College of Cardiology Board Review Course. Chicago, Illinois September, 2001
250. New and evolving therapies of atrial fibrillation and flutter Satellite Symposium, European Society of Cardiology Scientific Session. Stockholm, Sweden September, 2001
251. Pharmacologic therapy of AF and other cardiac arrhythmias Puerto Chapter of the American College of Cardiology. San Juan, Puerto Rico June, 2001
252. Review of pharmacology presentations Plenary Session, North American Society of Pacing and Electrophysiology Scientific Session. Boston, Massachusetts May, 2001
253. Clinical trials in rhythm management Cardiology Grand Rounds, Deborah Heart & Lung Center, Browns Mills, New Jersey May, 2001
254. Modern therapy of atrial fibrillation Eastern Virginia Medical School. Norfolk, Virginia May, 2001
255. Use of potassium replacement for prevention and treatment of cardiac disease Women’s Health Symposium. Washington, D.C., May, 2001
256. Emergency treatment of cardiac arrhythmias Satellite Symposium, North American Society of Pacing and Electrophysiology Scientific Session. Boston, Massachusetts May, 2001
257. Intravenous antiarrhythmic therapy for refractory VT/VF. Cardiology Grand Rounds, Cooper Hospital University Medical Center. Camden, New Jersey April, 2001
258. New agents of pharmacologic therapy of atrial fibrillation Cardiology Grand Rounds, Northwestern University. Chicago, Illinois April, 2001
259. What clinicians need to know about intravenous antiarrhythmic drugs Symposium, American College of Cardiology Scientific Sessions. Orlando, Florida, March, 2001
260. Management of malignant refractory ventricular arrhythmias Medical Grand Rounds, Albert Einstein Medical Center. Philadelphia, Pennsylvania, February, 2001
261. Pharmacology of antiarrhythmic drugs and case discussion Mayo Clinic Arrhythmia Symposium. Napa Valley, California February, 2001
262. New concepts in arrhythmia management Visiting Professor, Emory University and Grady Hospital. Atlanta, Georgia January, 2001
263. Fellows mentoring program in cardiac arrhythmia Chair. Dallas, Texas, January January, 2001
264. AF management Cardiology Grand Rounds, St. Francis Hospital. Hartford, Connecticut January, 2001
265. Pharmacological therapy of AF. Medical Grand Rounds, Eisenhower Medical Center. Palm Desert, California November, 2000
266. New concepts in the treatment of atrial fibrillation Cardiology Grand Rounds, University of California, Irvine. Irvine, California, November, 2000
267. New issues in the pharmacology of resuscitation University of Massachusetts Symposium. Dallas, Texas November, 2000
268. What’s new in ACLS Satellite Symposium Chair, American Heart Association Scientific Session. New Orleans, Louisiana November, 2000
269. Pharmacologic approaches to the management of AF Satellite Symposium, American Heart Association Scientific Session. New Orleans, Louisiana November, 2000
270. AF: Acute management Plenary Session, American Heart Association Scientific Session. New Orleans, Louisiana November, 2000
271. How to manage ventricular ectopy Cardiology for the non-cardiologist. Symposium. New York City, New York October, 2000
272. The QT issue symposium Association of Clinical Pharmacology Unite. Philadelphia, Pennsylvania October, 2000
273. Management of intractable ventricular tachycardia Cardiology Grand Rounds, Harper Hospital. Detroit, Michigan October, 2000
274. What’s new in clinical trials Heart Beats Fast and Slow. Symposium. Cleveland, Ohio September, 2000
275. Practical aspects of arrhythmia diagnosis and management American College of Cardiology, Satellite Symposium Chair. Philadelphia, Pennsylvania September, 2000
276. Clinical management of atrial fibrillation Cardiology Grand Rounds, University of Florida. Gainesville, Florida, September, 2000
277. New trends in rhythm management Symposium Chair. Los Angeles, California September, 2000
278. New aspects of AF management. Medical Grand Rounds, Cape Cod Hospital. Hyannis, Massachusetts September, 2000
279. Management of arrhythmias for cardiac surgery Satellite Symposium, European Society of Cardiology. Amsterdam, Netherlands August, 2000
280. New drugs for patients with atrial arrhythmias a regulatory perspective Cardiology Rounds, Massachusetts General Hospital. Boston, Massachusetts June, 2000
281. Treatment of cardiac arrhythmia Consultants Symposium. Detroit, Michigan, June, 2000
282. Treatment options for AF Medical Grand Rounds, High Point Hospital. High Point, North Carolina June, 2000
283. Practical issues in AF management Co-Chair, Symposium. Palm Beach, Florida June, 2000
284. Generic arrhythmic drugs. Co-Chair, FDA Symposium. North American Society of Pacing and Electrophysiology Scientific Sessions. Washington, D.C., May, 2000
285. Case-based arrhythmias Symposium Chair, Satelite Symposium, North American Society of Pacing and Electrophysiology Scientific Sessions. Washington, D.C., May, 2000
286. Inherited pre-disposition to sudden cardiac death Co-chairperson, North American Society of Pacing and Electrophysiology Meetings. Washington, D.C., May, 2000
287. Clinical Issues in AF management Satellite Symposium, American College of Physicians National Scientific Meeting. Philadelphia, Pennsylvania April, 2000
288. Arrhythmia in heart failure Cardiology Rounds, Columbia Presbyterian Medical Center. New York, New York March, 2000
289. Old and new arrhythmic drugs Symposium, American College of Cardiology Scientific Sessions. Anaheim, California March, 2000
290. Management of arrhythmia after cardiac surgery Satelite Symposium, American College of Cardiology Scientific Sessions. Anaheim, California March, 2000
291. Parenteral arrhythmic drugs Medical Grand Rounds, West Penn Hospital. Pittsburgh, Pennsylvania March, 2000
292. Update on clinical trials in arrhythmia Cardiology Grand Rounds, University of Miami. Miami, Florida, February, 2000
293. Acute interventions for supraventricular arrhythmias Satellite symposium, Society of Critical Care Medicine. Orlando, Florida February, 2000
294. Arrhythmia management in patients with heart failure Symposium Co-Chair. Cancun, Mexico January, 2000
295. Fellow Mentoring Symposium and Seminars. Palm Springs, California January, 2000
296. Drug treatment of atrial fibrillation Symposium. Tampa, Florida December, 1999
297. Arrhythmias in congestive heart failure American Heart Association Symposium. Philadelphia, Pennsylvania December, 1999
298. Review of cardiac arrhythmia management Symposium, Co-Chair. St. Louis, Missouri November, 1999
299. Post coronary surgery atrial arrhythmias Satellite symposium, American Heart Association meeting. Atlanta, Georgia November, 1999
300. New directions in arrhythmia management Symposium. Palm Springs, Florida October, 1999
301. Antiarrhythmic drug therapy in management of cardiac arrhythmias George Washington University Symposium. Washington, D.C., October, 1999
302. Review of atrial fibrillation management Jefferson Medical College Symposium. Hot Springs, Virginia October, 1999
303. Antiarrhythmic drug development Grand Rounds, Lenox Hill Hospital. New York, New York October, 1999
304. Acute AF treatment Symposium. New York City, New York October, 1999
305. Cardiac rhythm management American College of Cardiology Regional meeting. Denver, Colorado September, 1999
306. Contemporary management of cardiac arrhythmias Program Chair. Beverly Hills, California September, 1999
307. Atrial Fibrillation Symposium and Roundtable Co-Chair. St. Andrew's, Scotland August, 1999
308. New pharmacology in the treatment of patients with atrial fibrillation Symposium. Boston, Massachusetts July, 1999
309. Issues in the management of patients with atrial fibrillation: Pharmacologic and non-pharmacologic management Roundtable discussion. Big Sky, Montana July, 1999
310. Atrial fibrillation in the new millennium Symposium Co-Chair. Jackson Hole, Wyoming July, 1999
311. Issues in the design of clinical trials in cardiology Symposium. Milwaukee, Wisconsin June, 1999
312. Antiarrhythmic drugs in patients with ventricular arrhythmias and implantable devices Symposium, Montauk, New York June, 1999
313. Clinical trials in the development of new antiarrhythmic drugs Cardiology Grand Rounds, University of Michigan. Ann Arbor, Michigan June, 1999
314. Future of antiarrhythmic drug development Penn State Symposium. Hershey, Pennsylvania June, 1999
315. Pharmacologic management of atrial fibrillation The Jeresaty Symposium. Hartford, Connecticut May, 1999
316. Parenteral antiarrhythmic drugs. International Congress on Heart Disease, Plenary Session. Washington, D.C., May, 1999
317. Drug therapy of specific arrhythmias Co-chair, Core Curriculum. North American Society of Pacing and Electrophysiology. Toronto, Canada May, 1999
318. Pharmacokinetics of amiodarone Clinical Trials Session, North American Society of Pacing and Electrophysiology. Toronto, Canada May, 1999
319. Beta blocker trials in congestive heart failure North American Society of Pacing and Electrophysiology, Featured Symposium. Toronto, Canada May, 1999
320. Atrial fibrillation Symposium. Chairman. North American Society of Pacing and Electrophysiology, Satellite Symposium. Toronto, Canada May, 1999
321. The Arrhythmia Challenge Chairman. Jefferson University Symposium. Toronto, Canada May, 1999
322. Parenteral antiarrhythmic drug therapy Cardiology Grand Rounds, Rochester General Hospital. Rochester, New York April, 1999
323. Presentation of the sotalol database for approval for atrial fibrillation and atrial flutter CardioRenal Advisory Committee, Food and Drug Administration. Washington, D.C., April, 1999
324. Clinical trials and how they impact on arrhythmia management Symposium. Chicago, Illinois April, 1999
325. Antiarrhythmic drugs for acute management of cardiac arrhythmia Cardiology Grand Rounds, University of Louisville. Louisville, Kentucky April, 1999
326. Everything you wanted to know about Class IC and Class III antiarrhythmic drugs Symposium. New York, New York April, 1999
327. Issues in the pharmacologic therapy of atrial fibrillation Cardiology Grand Rounds, University of Southern California. Los Angeles, California April, 1999
328. Management of patients with perioperative arrhythmia Johns Hopkins University Satellite Symposium, American College of Cardiology. New Orleans, Louisiana March, 1999
329. Measures for the acute treatment and prevention of atrial fibrillation University of Southern California Symposium. Lake Tahoe, Nevada March, 1999
330. Drug therapy of atrial fibrillation. Meet the Experts Session at American College of Cardiology. new Orleans, Louisiana March, 1999
331. Practical issues in the management of patients with atrial fibrillation Jefferson Medical College Satellite Symposium, American College of Cardiology. New Orleans, Louisiana March, 1999
332. The pharmacology of amiodarone Penn State University Satellite Symposium, American College of Cardiology. New Orleans, Louisiana March, 1999
333. The evaluation of patients with syncope Canadian Electrophysiologist Society Symposium. Whistler Mountain, Canada January, 1999
334. Clinical management of AF Catalyst Symposium. Pittsburgh, Pennsylvania December, 1998
335. Cardiac arrest - new approaches Cardiology Grand Rounds, New York Medical College. Valhalla, New York December, 1998
336. Parenteral antiarrhythmic drugs University of Medicine and Dentistry of New Jersey Symposium. Newark, New Jersey, December, 1998
337. Malignant ventricular arrhythmias Medical Grand Rounds, St. Raphael Hospital, New Haven, Connecticut December, 1998
338. Refractory life-threatening ventricular arrhythmia Cardiology Grand Rounds, University of Cincinnati. Cincinnati, Ohio, December, 1998
339. AF Pharmacologic Conversion Cardiovascular Seminar at the National Scientific Sessions of the Americans Heart Association. Dallas, Texas November, 1998
340. Intravenous antiarrhythmic drug therapy UCLA Satellite Symposium at the American Heart Association meeting. Dallas, Texas, November, 1998
341. AF Symposium, Chairman Jefferson Medical College Symposium. Lake Louise, Alberta, Canada October, 1998
342. Clinical trials Cardiology Ground Rounds, Brigham and Womens Hospital. Boston, Massachusetts October, 1998
343. Update on amiodarone Grand Rounds, New York Hospital at Queens. Queens, New York October, 1998
344. Atrial fibrillation Practical management. Allegheny University Symposium. Lafayette Hills, Pennsylvania October, 1998
345. Parenteral drug therapy for cardiac arrhythmia UCLA Symposium. Los Angeles, California October, 1998
346. AF treatment dilemmas Cardiology Grand Rounds, University of Illinois. Urbana, Illinois September, 1998
347. Acute management of ventricular tachycardia Cardiology Grand Rounds, Hartford Hospital. Hartford, Connecticut September, 1998
348. Antiarrhythmic drug therapy of supraventricular arrhythmia Lion Hearted Symposium. Hershey, Pennsylvania September, 1998
349. Management of AF in the post-operative patients Cardiology Grand Rounds, Penn State University. Hershey, Pennsylvania September, 1998
350. Management of ventricular arrhythmia Cardiology Grand Rounds, Robert Wood Johnson Hospital. Hamilton, New Jersey September, 1998
351. Atrial fibrillation management Columbia University Symposium. Lake George, New York August, 1998
352. Cardiac arrest management Grand Rounds, Kent Hospital, Warwick, Rhode Island July, 1998
353. Current strategies for treatment of ventricular arrhythmias. Cardiology Grand Rounds, Medical College of Pennsylvania. Philadelphia, Pennsylvania June, 1998
354. Practical management of ventricular arrhythmia patients American College of Cardiology, Satellite Symposium. Orlando, Florida, June, 1998
355. Masters in Cardiology Program University of Miami. Orlando, Florida May, 1998
356. Acute termination of atrial arrhythmias University of Florida Symposium. Kiawah Island, South Carolina May, 1998
357. Cardiac arrest trials Emergency Medicine Grand Rounds, Montefiore Hospital. New York, New York, May, 1998
358. Current issues in use of amiodarone Clinical Tutorial, North American Society of Pacing and Electrophysiology. San Diego May, 1998
359. Renaissance in arrhythmia management Jefferson Medical College Symposium. San Diego, California May, 1998
360. Developing an EP practice Mini-Symposium, North American Society of Pacing and Electrophysiology meeting. San Diego, California May, 1998
361. Atrial fibrillation Columbia University Symposium. San Diego, California May, 1998
362. Treatment of VT - What have we learned in the last year? University of Texas and ACC Symposium. Santa Fe, New Mexico April, 1998
363. Acute care with parenteral antiarrhythmics Emergency Medicine Grand Rounds, Orlando Regional Medical Center. Orlando, Florida April, 1998
364. Atrial Fibrillation Berlex Symposium. Dallas, Texas April, 1998
365. Post MI ventricular arrhythmias Meet the Experts, National Scientific Session of the American College of Cardiology. Atlanta, Georgia March, 1998
366. Mortality trials. Satellite symposium, American College of Cardiology meetings. Atlanta, Georgia March, 1998
367. Contemporary trials in ventricular arrhythmias Penn State Symposium. Atlanta, Georgia March, 1998
368. Atrial fibrillation Medical Grand Rounds, St. Vincent's Hospital. New York, New York March, 1998
369. Neurocardiogenic syncope Medical Grand Rounds, Halifax Hospital. South Boston, Virginia March, 1998
370. Atrial fibrillation Jefferson Medical College Symposium (Chairman). Vermont, January, 1998
371. Ventricular arrhythmia trials after MADIT and AVID. University of Medicine and Dentistry of New Jersey. Newark, New Jersey January, 1998
372. The cardiovascular drug approval process. Cardiology Grand Rounds, Hospital of the University of Pennsylvania. Philadelphia, Pennsylvania January, 1998
373. Results of recent arrhythmia trials Cardiology Grand Rounds, Tulane University. New Orleans, Louisiana December, 1997
374. Drugs for treating VT/VF: A paradigm shift Medical College of Virginia Symposium at the American Association of Hospital Pharmacists Meeting. Atlanta, Georgia December, 1997
375. Post-surgical treatment of AF. Baptist Hospital Symposium. Nashville, Tennessee November, 1997
376. Post-MI trial review Penn State University Symposium at AHA Scientific Sessions. Orlando, Florida November, 1997
377. Drugs for treating VT/VF: A paradigm shift University of Washington Symposium. Orlando, Florida November, 1997
378. Rate vs. rhythm control in AF Medical Grand Rounds, Allegheny University, Graduate Hospital. Philadelphia, Pennsylvania November, 1997
379. American College of Emergency Physicians Satellite Symposium. San Francisco, California Cardiology Conference, Brown University. Providence, Rhode Island October, 1997
380. New treatments for VT/VF American College of Emergency Physicians Satellite Symposium. San Francisco, California October, 1997
381. Antiarrhythmic drugs in AF and SVT. Deborah Hospital Symposium. Browns Mills, New Jersey October, 1997
382. When to refer to EP practice. Sierra Heart Institute Symposium. Lake Tahoe, Nevada September, 1997
383. Syncope. ACC Colloquium on Cardiovascular Therapy. Santa Fe, New Mexico September, 1997
384. Management strategies for AF Medical Grand Rounds, Cooper Hospital. Camden, New Jersey September, 1997
385. Acute pharmacological management of AF University of Florida Symposium. Amelia Island, Florida September, 1997
386. The FDA drug approval process Medical Grand Rounds, Columbia University. New York, New York September, 1997
387. Ventricular arrhythmia management Medical Grand Rounds, Pennsylvania Hospital. Philadelphia, Pennsylvania September, 1997
388. Modern approach to atrial fibrillation Jefferson Medical College Symposium. Anchorage, Alaska August, 1997
389. Strategies for AF Allegheny University Symposium. Co-Chair. Lake George, New York, July, 1997
390. Management of AF Mercer County Cardiovascular Society. Trenton, New Jersey, June, 1997
391. Management of AF Satellite Symposium, ICU '97. Ottawa, Canada June, 1997
392. New treatments for AF. Medical Grand Rounds, Albert Einstein Medical Center. New York, New York June, 1997
393. Rate control versus rhythm control for AF Berlex Symposium. Newport Beach, California June, 1997
394. Atrial fibrillation Cardiology Grand Rounds, Western Pennsylvania Hospital. Pittsburgh, Pennsylvania June, 1997
395. Are calcium channel blockers safe? Core Curriculum National Scientific Sessions, North American Society of Pacing and Electrophysiology. New Orleans, Louisiana May, 1997
396. Ventricular arrhythmias in congestive heart failure Cardiology Grand Rounds, Rush-Presbyterian-St. Luke's Medical Center. Chicago, Illinois May, 1997
397. Current management of atrial fibrillation American Heart Association Symposium. Kiamesha, New York May, 1997
398. Anticoagulant treatment of atrial fibrillation Berlex Symposium. Dallas, Texas April, 1997
399. Cardiac arrhythmias: When do you need a specialist? Pinnacle Conference. Harrisburg, Pennsylvania April, 1997
400. Clinical trials of ventricular arrhythmias Baystate Cardiology Symposium. Springfield, Massachusetts April, 1997
401. Management of nonlethal ventricular arrhythmias American College of Cardiology Symposium. Orlando, Florida April, 1997
402. Ventricular arrhythmias management Cardiology Grand Rounds, University of California at San Diego. San Diego, California April, 1997
403. Managing acute atrial fibrillation Meet the Experts. National Scientific Sessions, American College of Cardiology, Anaheim, California March, 1997
404. Management of patients with AF Jefferson Medical College Symposium. Puerto Vallarta, Mexico March, 1997
405. Controversies in cardiology. Co-Chair. National Scientific Sessions, American College of Cardiology, Anaheim, California March, 1997
406. Ibutilide for postcoronary artery surgery atrial arrhythmias Late-Breaking Clinical Trials Symposium, National Scientific Sessions, American College of Cardiology, Anaheim, California March, 1997
407. Acute intervention for cardiac arrhythmia Cardiology Grand Rounds, Jackson Memorial Hospital. Miami, Florida February, 1997
408. Antiarrhythmic drug selection in patients with LVH and AF University of Southern California Symposium. Lake Tahoe, Nevada January, 1997
409. Parenteral antiarrhythmic drug therapy Washington DC EP Society. Washington, DC January, 1997
410. Intravenous antiarrhythmic drug therapy Medical Grand Rounds, Beth Israel Medical Center. New York, New York November, 1996
411. Prevention of sudden cardiac death in patients with congestive heart failure Long Island Jewish Medical Center Satellite Symposium at the American Heart Association Scientific Session. New Orleans, Louisiana November, 1996
412. Parenteral antiarrhythmic drug therapy in a modern era Cardiology Grand Rounds, New York Hospital/Cornell Medical Center. New York, New York November, 1996
413. How to manage tachyarrhythmias in the critical care setting National Scientific Session of the American Heart Association. New Orleans, Louisiana November, 1996
414. Parenteral antiarrhythmic drug therapy for the treatment of malignant ventricular arrhythmia Medical Grand Rounds, VA Medical Center. New York, New York November, 1996
415. Evaluation and treatment of ventricular arrhythmia in the era of the implantable cardioverter/defibrillator Deborah Hospital Symposium. Browns Mills, New Jersey October, 1996
416. Acute termination of atrial fibrillation. Cardiology Grand Rounds, West Roxbury VA Medical Center. West Roxbury, Massachusetts October, 1996
417. Anticoagulation in atrial fibrillation Mount Sinai Hospital Symposium. Detroit, Michigan October, 1996
418. The atrial fibrillation pandemic Cardiology Grand Rounds, University of Rochester. Rochester, New York October, 1996
419. Prevention of sudden death after myocardial infarction Allegheny University Symposium. Philadelphia, Pennsylvania October, 1996
420. Intravenous antiarrhythmic drug therapy Cardiology Grand Rounds, University of Texas at Houston. Houston, Texas September, 1996
421. Acute and chronic therapy of atrial fibrillation Grand Rounds, Texas Heart Institute/St. Luke's Hospital. Houston, Texas September, 1996
422. Acute therapy of ventricular arrhythmia Cardiology Grand Rounds, Albert Einstein Medical Center. Philadelphia, Pennsylvania September, 1996
423. An overview of the treatment of atrial fibrillation: Focus on patients who have had coronary surgery Columbia University Symposium. Lake George, NY August, 1996
424. Atrial fibrillation in patients with hypertensive heart disease University of Southern California Symposium. Lanai, Hawaii August, 1996
425. Acute treatment of ventricular arrhythmia Miami Florida Electrophysiology Society. Miami, Florida July, 1996
426. Treatment of Catastrophic Cardiac Arrhythmias Medical Grand Rounds, Wake Medical Center Raleigh, North Carolina June, 1996
427. AF-Case Workshop Development Meeting Medical College. San Juan, Puerto Rico June, 1996
428. New treatments of atrial fibrillation University of Southern California Symposium. Aruba, May, 1996
429. The acute management of ventricular arrhythmia Hartford Jeresaty Symposium. Hartford, Connecticut May, 1996
430. Arrhythmia treatment in the era of managed care Cardiology Grand Rounds, University of Massachusetts Medical Center. Worcester, May, 1996
431. New advances in the treatment of cardiac arrhythmia Medical Grand Rounds, Polyclinic Hospital. Harrisburg, Pennsylvania May, 1996
432. Chemical conversion of atrial fibrillation/flutter National Scientific Sessions of the North American Society of Pacing and Electrophysiology. Seattle, Washington May, 1996
433. Establishing an electrophysiology practice Managing Managed Care, Satellite Symposium at North American Society of Pacing and Electrophysiology Meeting. Seattle, Washington May, 1996
434. Ventricular hypertrophy: Implications for the genesis of arrhythmias Cardiology Grand Rounds, Milton S. Hershey Medical Center of Penn State University. Hershey, Pennsylvania, April, 1996
435. New advances in the treatment of cardiac arrhythmias Medical Grand Rounds, Reading Hospital. Reading, Pennsylvania April, 1996
436. Ablation treatment for arrhythmias: Do I really need to know this? Cardiology for the Non-Cardiologist Symposium, Boston University. Boston, Massachusetts April, 1996
437. Ongoing controversies in the management of patients with non-sustained ventricular tachycardias Boston University Satellite Symposium at American College of Cardiology Meeting. Orlando, Florida March, 1996
438. Asymptomatic Dysrhythmias Core Curriculum. National Scientific Sessions of the American College of Cardiology. Orlando, Florida March, 1996
439. New and old therapy of ventricular tachycardia Cardiology Grand Rounds. Case Western Reserve University. Cleveland, Ohio February, 1996
440. Clinical management of cardiac arrhythmias. Extramural Program, American College of Cardiology. Philadelphia, Pennsylvania December, 1995
441. Pharmacologic considerations in antiarrhythmic drug therapy Symposium. Palm Springs, California December, 1995
442. Intravenous antiarrhythmic drug therapy Columbia University Symposium. New York, New York December, 1995
443. Pharmacologic vs. Device Therapy of cardiac arrhythmias Symposium. Appleton, Wisconsin November, 1995
444. Intravenous amiodarone Grand Rounds, Walter Reed Army Hospital. Washington, D.C., November, 1995
445. Treatment of supraventricular arrhythmia Medical Grand Rounds, Paoli Memorial Hospital. Paoli, Pennsylvania November, 1995
446. Clinical management of nonsustained VT. University of Massachusetts Symposium. Worcester, Massachusetts October, 1995
447. AF: Management options Deborah Hospital Symposium. Browns Mills, New Jersey October, 1995
448. Intravenous antiarrhythmic drug therapy Satellite Symposium, Canadian Cardiovascular Society. Toronto, Ontario, Canada October, 1995
449. Pharmacologic considerations in antiarrhythmic drug use Symposium. Dallas, Texas October, 1995
450. Contemporary arrhythmia management Symposium Chairman, Jefferson Medical College. Lake Louise, Canada September, 1995
451. Pharmacologic therapy of cardiac arrhythmias Grand Rounds, Winthrop Hospital. Long Island, New York September, 1995
452. New concepts in drug therapy for ventricular arrhythmias Cardiology Research Conference, Northwestern Medical School. Chicago, Illinois September, 1995
453. Post-infarction prophylaxis University of Florida Symposium. Jacksonville, Florida September, 1995
454. Non-sustained VT: Should I be concerned University of Massachusetts Symposium. Hancock, Massachusetts July, 1995
455. Antiarrhythmic drug therapy of AF Kimball Medical Center. Lakewood, New Jersey, July, 1995
456. Life-threatening arrhythmia Visiting Professor, Cleveland Clinic Foundation. Cleveland, Ohio June, 1995
457. Drug therapy of cardiac arrhythmia Symposium. Amelia Island, Florida May, 1995
458. New treatment for malignant ventricular arrhythmia Western New York Cardiovascular Society. Buffalo, New York May, 1995
459. Clinical management of AF. Grand Rounds, Ashville Clinic. Ashville, North Carolina May, 1995
460. Life-threatening ventricular arrhythmia New York Cardiovascular Society. Albany, New York May, 1995
461. AF and anticoagulation Satellite Symposium at the Scientific Sessions of the North American Society of Pacing and Electrophysiology. Boston, Massachusetts May, 1995
462. Electrophysiology Practice in the Managed Care Environment Core Curriculum. North American Society of the Pacing and Electrophysiology. Boston, Massachusetts May, 1995
463. Clinical predictors of response to IV amiodarone Scientific Sessions of the North American Society of Pacing and Electrophysiology. Boston, Massachusetts May, 1995
464. Safety profile of IV amiodarone. Indiana University Satellite Symposium North American Society of Pacing and Electrophysiology. Boston, Massachusetts May, 1995
465. Diagnosis and management of supraventricular arrhythmias University of Southern California Symposium. Vail, Colorado April, 1995
466. Radiofrequency catheter ablation of arrhythmia: How far have we come? Episcopal Heart Institute Symposium. Philadelphia, Pennsylvania April, 1995
467. Ablation treatment for arrhythmias: Do I really need to know this? Cardiology for the Non-Cardiologist Symposium, Boston University. Boston, Massachusetts April, 1995
468. Tricks of the trade: Management of non-sustained VT Core Curriculum. National Scientific Sessions of the American College of Cardiology. New Orleans, Louisiana March, 1995
469. Matching clinical profiles with drug mechanism: Effective treatment of AF Columbia University Symposium. Cancun, Mexico March, 1995
470. Intravenous antiarrhythmic agents Satellite Symposium, American College of Cardiology. New Orleans, Louisiana March, 1995
471. Classification and diagnosis of supraventricular arrhythmia Symposium. Naples, Florida December, 1994
472. Improving survival after myocardial infarction Cardiology Grand Rounds, Coney Island Hospital. Coney Island, New York December, 1994
473. Antiarrhythmic drug therapy Medical Staff Rounds Hackettstown Community Hospital. Hackettstown, New Jersey November, 1994
474. Life-threatening arrhythmias: Drugs and devices Medical Grand Rounds, Mercy Catholic Medical Center, Fitzgerald Division. Lansdowne, Pennsylvania November, 1994
475. Diagnosis and treatment of ventricular arrhythmia Cardiology Grand Rounds, Episcopal Hospital. Philadelphia, Pennsylvania November, 1994
476. Overall safety data for intravenous amiodarone National Scientific Sessions of the American Heart Association. Dallas, Texas November, 1994
477. Intravenous antiarrhythmic drug therapy in the 1990's UCLA Symposium. Dallas, Texas November, 1994
478. Pharmacologic treatment for patients with atrial fibrillation University of Southern California Symposium. Hawaii, Hawaii, November, 1994
479. Treatment of life-threatening ventricular arrhythmia Cardiology Grand Rounds, University of Virginia Health Science Center. Charlottesville, Virginia October, 1994
480. Drugs versus devices for the treatment of ventricular arrhythmia Symposium Boston University. Boston, Massachusetts October, 1994
481. Chronic pharmacologic management of supraventricular and ventricular arrhythmia American College of Cardiology Board Review Course. Philadelphia, Pennsylvania September, 1994
482. The use of devices for the treatment of patients with cardiac arrhythmia Grand Rounds Riddle Memorial Hospital. Media, Pennsylvania September, 1994
483. Pharmacologic principles and use of antiarrhythmic drugs Symposium Lake Louise. Alberta, Canada September, 1994
484. The use of intravenous antiarrhythmic drugs for the treatment of highly malignant ventricular arrhythmia. Symposium Stanford University. Palo Alto, California September, 1994
485. The differential diagnosis of supraventricular tachycardia Symposium LaCosta Resort. Carlsbad, California August, 1994
486. Pharmacologic considerations in the use of antiarrhythmic drugs Columbia University Symposium. Lake George, New York July, 1994
487. Indications for electrophysiologic testing Hamot Medical Center, Erie, Pennsylvania July, 1994
488. The care of the postmyocardial infarction patient Medical Grand Rounds, Bryn Mawr Hospital, Bryn Mawr, Pennsylvania June, 1994
489. Drugs vs devices for malignant cardiac arrhythmia University of Miami. Masters Cardiology Conference. Orlando, Florida May, 1994
490. Implantable arrhythmia control devices - What's new? Keystone Crozier Alliance Symposium. Lafayette Hills, Pennsylvania May, 1994
491. Atrial fibrillation/flutter treatment Medical Grand Rounds, St. Luke's Hospital. Bethlehem, Pennsylvania May, 1994
492. Organizational and economic aspects of EP practice Minicourse at National Scientific Session of NASPE. Nashville, TN May, 1994
493. Management of the patient with atrial fibrillation St. Francis Hospital Symposium, Hartford, Connecticut May, 1994
494. Update on arrhythmia management Columbia University Symposium. Philadelphia, Pennsylvania April, 1994
495. Evaluation and treatment of atrial fibrillation Grand Rounds, Deborah Heart Hospital. Browns Mills, New Jersey April, 1994
496. Management of highly malignant ventricular arrhythmias Cardiology Grand Rounds, Columbia University, New York April, 1994
497. Modern management of atrial fibrillation Medical Grand Rounds. Toledo Hospital, Toledo, Ohio April, 1994
498. Generic substitution issues in antiarrhythmic therapy Ochsner Clinic Symposium. Puerto Vallarta, Mexico April, 1994
499. Generic substitution issues in antiarrhythmic therapy University of Southern California Symposium. Squaw Creek, California February, 1994
500. New concepts in the management of cardiac arrhythmia Medical Grand Rounds. Roger Williams Hospital, Providence, Rhode Island February, 1994
501. Amiodarone for atrial fibrillation Medical Grand Rounds. Jersey City Medical Center, Jersey City, New Jersey February, 1994
502. New drugs for atrial fibrillation Medical Grand Rounds. Lenox Hill Hospital, New York January, 1994
503. Management of ventricular arrhythmia post-infarction Cardiology Grand Rounds. Shadyside Hospital, Pittsburgh, Pennsylvania December, 1993
504. Treatment of ventricular arrhythmias that are less than sustained American College of Cardiology Symposium. Hahnemann University. Philadelphia, Pennsylvania December, 1993
505. The results of the multicenter intravenous amiodarone versus bretylium comparative study National Scientific Sessions, American Heart Association, Atlanta, Georgia November, 1993
506. Indications for treatment of asymptomatic ventricular arrhythmia Columbia University Symposium. Atlanta Georgia November, 1993
507. Improving survival after myocardial infarction Medical Grand Rounds, Quakertown Hospital, Quakertown, Pennsylvania November, 1993
508. Drugs in the treatment of cardiac arrhythmia Virginia Heart Association Symposium. Alexandria, Virginia October, 1993
509. Arrhythmias and left ventricular hypertrophy Medical Grand Rounds, Abington Hospital, Abington, Pennsylvania October, 1993
510. Clinical application of post-infarction therapy Medical Grand Rounds, Hazelton Hospital, Hazelton, Pennsylvania October, 1993
511. Arrhythmia management in 1993 Boston University Symposium. Boston, Massachusetts, October, 1993
512. Improving survival after myocardial infarction Medical Grand Rounds, VA Medical Center, Wilkes Barre, Pennsylvania October, 1993
513. What the internist needs to know about atrial fibrillation. Medical Grand Rounds, Thomas Jefferson University. Philadelphia, Pennsylvania, September, 1993
514. Pharmacologic therapy of cardiac arrhythmia Lankenau Symposium. Williamsburg, Virginia September, 1993
515. Differential diagnosis and management of wide-complex rhythms University of Florida Symposium. Amelia Island, Florida, September, 1993
516. Improving survival after myocardial infarction Medical Grand Rounds, St. Elizabeth's Hospital, Brighton, Massachusetts August, 1993
517. Diagnosis and treatment of supraventricular arrhythmia Rush-Presbyterian-St. Luke's Symposium. Lake George, New York July, 1993
518. Diagnosis and treatment of supraventricular arrhythmia University of Florida Symposium. Pinehurst, North Carolina June, 1993
519. Drugs and devices in treating cardiac arrhythmia Connecticut Electrophysiology Society Symposium. Hartford, Connecticut June, 1993
520. Heart rate control in atrial fibrillation and flutter Visiting Professorship, Ochsner Medical Foundation. New Orleans, Louisiana May, 1993
521. Non-sustained ventricular tachycardia National Scientific Sessions of NASPE (Chair, Clinical Tutorial). San Diego, California, May, 1993
522. Acute treatment of cardiac arrhythmias Emergency Medicine Grand Rounds, Hahnemann University. Philadelphia, Pennsylvania May, 1993
523. Treatment of the patient after a myocardial infarction Cardiology Grand Rounds, Columbia Presbyterian Medical Center. New York, New York April, 1993
524. Treatment of cardiac arrhythmia Visiting Professorship, University of Texas. Houston, Texas, April, 1993
525. Management of ventricular arrhythmia Ochsner Clinic Symposium. Aspen, Colorado April, 1993
526. Antiarrhythmic Drugs and Devices Lahey Clinic Symposium. Boston, Massachusetts March, 1993
527. How to approach atrial fibrillation Lankenau Symposium. Palm Beach, Florida March, 1993
528. Usefulness of lidocaine in patients with acute myocardial infarction National Scientific Sessions of American College of Cardiology. Anaheim, California March, 1993
529. The ESVEM study Cardiology Grand Rounds, Long Island Jewish Hospital. New Hyde Park, New York March, 1993
530. Treatment of ventricular arrhythmia after CAST. Hospital Symposium. Columbus, Ohio February, 1993
531. Evaluation and management of supraventricular arrhythmia USC Symposium. Cancun, Mexico February, 1993
532. Life-threatening arrhythmias. Underwood Memorial Hospital. Washington Township, New Jersey January, 1993
533. Management of atrial fibrillation and flutter Medical Grand Rounds, Doylestown Hospital. Doylestown, Pennsylvania January, 1993
534. Management of atrial fibrillation Medical Grand Rounds, Chestnut Hill Hospital. Philadelphia, Pennsylvania January, 1993
535. Hospital treatment of acute arrhythmia Medical Grand Rounds, Delaware County Memorial Hospital. Lansdowne, Pennsylvania January, 1993
536. Atrial fibrillation Grand Rounds, Community Medical Center. Toms River, New Jersey December, 1992
537. A review of ESVEM and its impact on antiarrhythmic therapy Grand Rounds, Long Island Jewish Hospital. New York, New York, December, 1992
538. Newer approaches to antiarrhythmic therapy Grand Rounds, Albert Einstein Medical Center. Philadelphia, Pennsylvania November, 1992
539. Old and new antiarrhythmic drugs Lankenau Hospital Symposium (Chair). Puerto Vallarata, Mexico November, 1992
540. Combination therapy in the treatment of cardiac arrhythmias Grand Rounds, White Plains and Lawrence Hospital. New York, New York November, 1992
541. Post-operative arrhythmias Grand Rounds, Episcopal Hospital. Philadelphia, Pennsylvania October, 1992
542. Current concepts in treatment of arrhythmias Cardiology Update Symposium. Philadelphia, Pennsylvania October, 1992
543. Practical aspects in managing arrhythmias (and tutorial). USC Symposium. Maui, Hawaii October, 1992
544. Heart rate control in AF. Grand Rounds, Albert Einstein Medical Center. New York, New York October, 1992
545. Modern management of atrial fibrillation Grand Rounds, Mount Sinai Medical Center. Miami, Florida October, 1992
546. Management of life-threatening ventricular arrhythmias University of Florida Symposium. Naples, Florida, September, 1992
547. Management of ventricular arrhythmias Carolina Physicians Symposium. Charlotte, North Carolina September, 1992
548. Arrhythmia management tutorial University of New Mexico and American College of Cardiology. Santa Fe, New Mexico September, 1992
549. Electrophysiology Board Review Course American College of Cardiology. Philadelphia, Pennsylvania September, 1992
550. Arrhythmia management: What constitutes appropriate therapy in 1992? University Symposium, Lake George, New York, August, 1992
551. Emerging trends in the management of cardiac arrhythmias (Chair). Lankenau Hospital Symposium. Marina del Rey, California August, 1992
552. Cardiac arrhythmias Issues in Management (Chair). Lankenau Hospital Symposium. Williamsburg, Virginia July, 1992
553. Management of AF after CABG Surgery Satellite to National Meetings of North American Society of Pacing and Electrophysiology, Chicago, Illinois May, 1992
554. NSVT: Who and when to treat. Clinical Tutorial National Meetings of North American Society of Pacing and Electrophysiology, Chicago, Illinois May, 1992
555. Case management workshop (Chair). Satellite to National Meetings of North American Society of Pacing and Electrophysiology, Chicago, Illinois May, 1992
556. Controversies in treatment of AF Satellite Symposium, National Meetings of North American Society of Pacing and Electrophysiology, Chicago, Illinois May, 1992
557. Arrhythmia management American Heart Association Symposium, Monticello, New York May, 1992
558. Cardiac arrhythmias St. Thomas Medical School Symposium, Atlantic City, New Jersey May, 1992
559. New medication and devices for arrhythmia St. Francis Hospital Symposium, Memphis, Tennessee May, 1992
560. Recent advances in the management of ventricular arrhythmia St. Francis Hospital Symposium, Hartford, Connecticut May, 1992
561. Cost impact of peri-operative arrhythmias National Sessions, American Federation for Clinical Research, Baltimore, Maryland May, 1992
562. sudden cardiac death Symposium on sudden cardiac death (Chair). Lankenau Hospital, Wynnewood, Pennsylvania April, 1992
563. Who should receive antiarrhythmic drugs and temporary pacemakers in the setting of an acute MI. Core Curriculum. National Scientific Sessions of the American College of Cardiology, Dallas, Texas April, 1992
564. Electrophysiologic testing in patients with life-threatening arrhythmias Ochsner Clinic Symposium, Vail, Colorado April, 1992
565. Meet the Professor. National Meetings of the American College of Physicians, San Diego, California March, 1992
566. Pitfalls in the management of malignant ventricular arrhythmias USC Symposium, Lake Tahoe, Nevada March, 1992
567. The sudden cardiac death syndrome Harrisburg Hospital Symposium, Harrisburg, Pennsylvania February, 1992
568. Treatment of supraventricular Arrhythmias Cardiology Conference. Meharry Medical School. Nashville, Tennessee, February, 1992
569. Cost and other issues in the selection of antiarrhythmic drugs International Congress. The New Frontiers of Arrhythmias. European Society of Cardiology. Marilleva, Italy, January, 1992
570. Sudden cardiac death Medical Grand Rounds, Robert Wood Johnson Medical School, Camden, New Jersey, January, 1992
571. Sudden cardiac death syndrome Temple University Symposium, Nazareth Hospital, Philadelphia, Pennsylvania January, 1992
572. Selected topics on ventricular arrhythmia Regional Symposium, American College of Cardiology, Philadelphia, Pennsylvania December, 1991
573. New IC drugs in management of ventricular arrhythmia Cardiology Grand Rounds, Roosevelt Hospital, New York December, 1991
574. Risk prediction and prevention after myocardial infarction Cardiology Grand Rounds, Bellevue Hospital, New York, December, 1991
575. Strengths/weaknesses of electrophysiologic testing Columbia University Symposium, Carlsbad, California November, 1991
576. Pharmacologic approaches to ventricular arrhythmia Chair, Cardiovascular Symposium. National Scientific Meeting of American Heart Association, Anaheim, California November, 1991
577. Management of ventricular arrhythmia Cardiology Grand Rounds, Deborah Hospital, Browns Mills, NJ, November, 1991
578. New modalities of antiarrhythmic therapy Symposium Chair, Atlanta, Georgia November, 1991
579. Electrophysiologic testing for drug efficacy UCLA Symposium, Beverly Hills, California October, 1991
580. Antiarrhythmic drug therapy for the sudden death victim Cardiology Grand Rounds, Tampa General Hospital, Tampa, Florida September, 1991
581. Sudden death prevention Symposium, Naples, Florida September, 1991
582. Antiarrhythmic drug therapy - Changing concepts Symposium, Brewster, Massachusetts September, 1991
583. New antiarrhythmic drugs Symposium, New York, New York August, 1991
584. Post-MI management - What's new Medical Grand Rounds, York Hospital, York, Pennsylvania August, 1991
585. New concepts in arrhythmia management Symposium, Lake George, New York August, 1991
586. Practical management of patients with cardiac arrhythmia Workshop Symposium, Philadelphia Arrhythmia Group, Absecon, New Jersey July, 1991
587. Combination antiarrhythmic drug therapy Georgetown University Symposium, Nantucket, Massachusetts July, 1991
588. New technology in treating cardiac arrhythmia Symposium, Newport Beach, California June, 1991
589. When to treat or ignore ventricular ectopy Ohio State Symposium, Columbus, Ohio June, 1991
590. Drug therapy of ventricular arrhythmia Cardiology Grand Rounds, Eastern Carolina University, Greenville, North Carolina June, 1991
591. Resistant SVTs: What to do? Boston University Symposium, Boston, Massachusetts May, 1991
592. Does programmed stimulation really help in patients with NSVT? World Congress of Cardiology, Washington, D.C., May, 1991
593. Drug therapy after CAST North American Society of Pacing and Electrophysiology Satellite Symposium, Washington, D.C., May, 1991
594. Management of SVT: Clinician's approach National Scientific Sessions of the American College of Physician, New Orleans, Louisiana April, 1991
595. New antiarrhythmic drugs Cardiology Grand Rounds, University of Medicine and Dentistry of New Jersey and Cooper Hospital, Camden, New Jersey, April, 1991
596. Non-pharmacologic therapy of ventricular arrhythmia USF Symposium, Tampa, Florida March, 1991
597. Pacemakers: Changing indications and usage Cardiology Grand Rounds, Thomas Jefferson University, Philadelphia, Pennsylvania March, 1991
598. Modern approach to patients with resistant cardiac arrhythmias Medical Grand Rounds, Brown University, Providence, Rhode Island March, 1991
599. Management of the patient with refractory SVT Core Curriculum. National Scientific Sessions of the American College of Cardiology, Atlanta, Georgia March, 1991
600. Hyperthyroidism and cardiac arrhythmia Satellite Symposium, American College of Cardiology Meetings, Atlanta, Georgia March, 1991
601. Investigational antiarrhythmic drugs Symposium, Atlanta, Georgia March, 1991
602. Management of the post-infarction patient. Focus on drug therapy. Program Co-Chairman, Symposium, Lake Tahoe, Nevada February, 1991
603. Clinical approach to the use of antiarrhythmic drugs Symposium, Orlando, Florida January, 1991
604. Implications of the CAST Indiana University Symposium, Fort Lauderdale, Florida December, 1990
605. New uses for old antiarrhythmic drugs. Medical Grand Rounds, Metropolitan Hospital, New York, New York December, 1990
606. Assessment of the patient with cardiac arrhythmia Symposium, American College of Cardiology and Hahnemann University, Philadelphia, Pennsylvania December, 1990
607. Risk stratification of ventricular arrhythmia patients University of Massachusetts Symposium, Boston, Massachusetts December, 1990
608. Current and future pharmacologic therapy of cardiac arrhythmia Symposium, National Scientific Sessions of the American Heart Association, Dallas, Texas November, 1990
609. Pharmacologic approaches to cardiac arrhythmia Medical Grand Rounds, University of Medicine and Dentistry of New Jersey, Newark, New Jersey November, 1990
610. New approaches to management of ventricular arrhythmia Symposium, Tucson, Arizona October, 1990
611. Innovations in arrhythmia management Symposium, Scottsdale, Arizona October, 1990
612. Management of ventricular arrhythmias Grand Rounds, Case Western Reserve University, Cleveland, Ohio October, 1990
613. Current concepts in arrhythmia management Medical Grand Rounds, Christ Hospital, Chicago, Illinois September, 1990
614. New and investigational antiarrhythmic drugs Symposium, Hilton Head, South Carolina September, 1990
615. New concepts in treatment of ventricular arrhythmias Symposium, LaCosta, California, September, 1990
616. New approaches to the management of cardiac arrhythmia Boston University Symposium, Cape Cod, Massachusetts August, 1990
617. Overview of management of patients with myocardial infarction Symposium, Colorado Springs, Colorado July, 1990
618. Management of ventricular arrhythmia Lloyd Noland Hospital Symposium, Hilton Head, South Carolina, July, 1990
619. Management options for the post-MI patient Roundtable discussion, Montreal, Canada June, 1990
620. Clinical issues in the selection of antiarrhythmic drugs Symposium, Orlando, Florida June, 1990
621. Relative value of invasive and non-invasive testing in patients with malignant arrhythmia Symposium, Tucson, Arizona June, 1990
622. Topics in clinical electrophysiology National Sessions of the North American Society of Pacing and Clinical Electrophysiology, San Diego, California June, 1990
623. Care and feeding of the post-MI patient Medical Grand Rounds, Kings County Hospital Center of Downstate University, New York, New York May, 1990
624. The continuum of basic to clinical development of antiarrhythmic agents. FDA Symposium, Washington, D.C May, 1990
625. Ventricular arrhythmia: When and how to treat Episcopal Hospital Symposium, Philadelphia, Pennsylvania May, 1990
626. Diagnosis of supraventricular tachycardia: The clinician's approach National Sessions of the American College of Physicians, Chicago, Illinois April, 1990
627. Treatment of ventricular arrhythmias after CAST Medical Grand Rounds, Sarasota Hospital, Sarasota, Florida March, 1990
628. Electrophysiologic effects of left ventricular hypertrophy National Scientific Sessions of the American College of Cardiology, New Orleans, Louisiana March, 1990
629. How to treat and not to treat ventricular arrhythmias Medical Grand Rounds, Roanoke General Hospital, Roanoke, Virginia March, 1990
630. Positioning new antiarrhythmic drugs Symposium, Stratton, Vermont March, 1990
631. Benefits and risks of antiarrhythmic drug therapy Symposium, Lake Tahoe, Nevada February, 1990
632. New concepts in the management of cardiac arrhythmia Medical Grand Rounds, Roger Williams Hospital, Providence, Rhode Island January, 1990
633. New antiarrhythmic drugs Symposium, Vail, Colorado January, 1990
634. Use of conventional antiarrhythmic drugs Symposium, Houston, Texas December, 1989
635. Managing nonsustained ventricular arrhythmia Cardiology Dinner Symposium, Jackson Hospital, Miami, Florida December, 1989
636. Clinical evaluation of ventricular arrhythmia American College of Cardiology Symposium, Philadelphia, Pennsylvania December, 1989
637. How to manage cardiac arrhythmias National Scientific Sessions of the American Heart Association,New Orleans, Louisiana November, 1989
638. Arrhythmias and left ventricular hypertrophy Symposium, Fort Lauderdale, Florida November, 1989
639. New antiarrhythmic drugs and devices Symposium, Puerto Vallarta, Mexico November, 1989
640. A new antiarrhythmic drug: propafenone Symposium, Glen Eagles, Scotland October, 1989
641. New antiarrhythmic drugs Symposium, Houston, Texas October, 1989
642. Management of the sudden death victim Cardiology Grand Rounds, Georgetown University, Washington, D.C., October, 1989
643. Clinical management of nonsustained ventricular tachycardia Symposium, Waterville, New Hampshire October, 1989
644. Positioning the newer antiarrhythmic drugs Symposium, Fort Lauderdale, Florida September, 1989
645. Promise and place of propafenone Symposium, Hot Springs, Virginia August, 1989
646. Management of nonsustained ventricular tachycardia Symposium, Blaine, Washington August, 1989
647. Management of malignant arrhythmias with the new pharmacology Symposium, Sagamore, New York July, 1989
648. New antiarrhythmic drugs Symposium, Hershey, Pennsylvania July, 1989
649. Antiarrhythmic therapy Cardiology Grand Rounds, University of Connecticut, Farmington, Connecticut July, 1989
650. Beta-blockers in the management of resistant cardiac arrhythmias Symposium, Dallas, Texas June, 1989
651. Ventricular arrhythmias accompanying left ventricular hypertrophy Symposium, Nassau, Bahamas June, 1989
652. Antiarrhythmic therapy Medical Grand Rounds, Cabrini Medical Center, New York, New York June, 1989
653. Use of amiodarone for treatment of resistant cardiac arrhythmias Cardiology Grand Rounds, Howard University and Washington Hospitals Center, Washington, D.C., May, 1989
654. Propafenone - A new antiarrhythmic agent Symposium, Lake of the Ozarks, Missouri May, 1989
655. New antiarrhythmic drugs. Symposium, Phoenix, Arizona April, 1989
656. Clinical Controversies in drug and device management of cardiac arrhythmia. Plenary Session, National Scientific Sessions of the American College of Physicians (Chairman), San Francisco, California, April, 1989
657. Devices for management of resistant cardiac arrhythmias Symposium, Hahnemann University, Philadelphia, Pennsylvania March, 1989
658. Approach to the patient with nonsustained ventricular tachycardia Cardiology Grand Rounds. Cooper Hospital, Camden, New Jersey February, 1989
659. Cardiac arrhythmia diagnosis and management workshop Keystone, Colorado February, 1989
660. Emergent management of cardiac arrhythmias Critical Care Symposium, University of Miami, Key Biscayne, Florida February, 1989
661. Device management of ventricular arrhythmia Symposium, Florida Medical Center, Fort Lauderdale, Florida December, 1988
662. Use of holter, exercise testing and signal-averaging in patients with ventricular arrhythmia American College of Cardiology Symposium, Philadelphia, Pennsylvania December, 1988
663. New management strategies for ventricular arrhythmia Medical Grand Rounds, Bowman Gray School of Medicine, Winston-Salem, North Carolina, December, 1988
664. Propafenone, A new antiarrhythmic drug Symposium Chairman, Puerto Vallarta, Mexico November, 1988
665. New Class III Antiarrhythmic drugs Cardiology Conference, Westchester, New York October, 1988
666. New Class I antiarrhythmic drugs Cardiology Conference, Hartford, Connecticut October, 1988
667. The beta-blocker renaissance Symposium Chairman, Atlantic City, New Jersey October, 1988
668. Management of ventricular arrhythmias in patients with congestive heart failure Symposium, Phoenix, Arizona October, 1988
669. When to treat ventricular arrhythmia after an MI Cardiology Update, Mount Sinai School of Medicine, New York, New York October, 1988
670. Thrombolysis - Practical aspects of therapy Medical Grand Rounds, Eastern Virginia Medical School, Norfolk, Virginia October, 1988
671. Promise and place of propafenone Cardiology Conference, New Orleans, Louisiana October, 1988
672. New antiarrhythmic pharmacology Medical Grand Rounds, Heineman Clinic, Charlotte, North Carolina September, 1988
673. Treatment of resistant cardiac arrhythmias Cardiology Conference, Lancaster, Pennsylvania September, 1988
674. Arrhythmias and congestive heart failure Symposium Chairman, Absecon, New Jersey September, 1988
675. Amiodarone for cardiac arrhythmia: Risks and benefit Cardiology Conference, West Roxbury, Massachusetts August, 1988
676. Amiodarone for cardiac arrhythmia: risks and benefit Cardiology Conference, Washington, D.C., June, 1988
677. Common sense approach to supraventricular tachyarrhythmias Medical Grand Rounds, Dartmouth-Hitchcock Medical Center, Hanover, New Hampshire June, 1988
678. New drug development Visiting Scientist, Merck, Sharp, and Dohme, West Point, Pennsylvania May, 1988
679. Indications for use of permanent cardiac pacing University of Medicine and Dentistry of New Jersey Symposium, Atlantic City, New Jersey May, 1988
680. K-channels: Focus on antiarrhythmic drug action A.N. Richards Symposium, Valley Forge, Pennsylvania May, 1988
681. Acute management of SVT Symposium, Staten Island, New York May, 1988
682. Ventricular arrhythmia and hypertension Symposium, Acapulco, Mexico April, 1988
683. Medical Management of SVT Cardiology Grand Rounds, SUNY, Downstate, Brooklyn, NY April, 1988
684. Propafenone for serious ventricular arrhythmias Symposium, Boston, Massachusetts April, 1988
685. Antiarrhythmic drug therapy for malignant ventricular arrhythmias Symposium, San Juan, Puerto Rico April, 1988
686. Class IC drugs for management of ventricular arrhythmia Symposium, Miami, Florida March, 1988
687. Treatment of ventricular arrhythmia Meet-the-Experts. Atlanta, Georgia March, 1988
688. Thrombolytic therapy for acute myocardial infarction. Symposium, Providence, Rhode Island March, 1988
689. Review of new antiarrhythmic drugs Symposium, Baptist Hospital, Memphis, Tennessee March, 1988
690. Acute Interventions for treatment of SVT Medical Grand Rounds, Maine Medical Center, Portland, Maine March, 1988
691. Thrombolytic therapy in acute myocardial infarction Cardiology Conference, Sacramento, California February, 1988
692. New antiarrhythmic drugs for ventricular arrhythmias Symposium, Long Island, New York February, 1988
693. Clinical use of antiarrhythmic drugs Symposium, Orlando, Florida January, 1988
694. Beta-blockers for cardiac arrhythmia Symposium, Houston, Texas December, 1987
695. Ventricular arrhythmia, when to treat American College of Cardiology Satellite Symposium, Philadelphia, Pennsylvania, December, 1987
696. Stress and cardiac arrhythmia Symposium Chairman, American Heart Association Meeting, Anaheim, California November, 1987
697. Management of ventricular arrhythmias Symposium Program Director, Puerto Vallarta, Mexico, November, 1987
698. Medical management of supraventricular tachycardia Cardiology Grand Rounds, Hartford Hospital, Hartford, Connecticut November, 1987
699. Propafenone therapy for cardiac arrhythmia Symposium, Atlanta, Georgia October, 1987
700. Adverse reaction to antiarrhythmic drugs: Prevention and treatment Canadian Cardiovascular Society Satellite Symposium, Edmonton, Canada October, 1987
701. Implantable devices in the management of drug-resistant cardiac arrhythmias University of South Florida Symposium, Tampa, Florida October, 1987
702. Beta-blocker in the management of cardiac arrhythmia University of Texas Symposium, New Orleans, Louisiana October, 1987
703. The use of propafenone for malignant ventricular arrhythmia Symposium, Pittsburgh, Pennsylvania October, 1987
704. Current trends in the medical and surgical management of supraventricular tachycardia Western New York Cardiovascular Society, Buffalo, New York September, 1987
705. New and investigational antiarrhythmic drugs Medical Grand Rounds, University Hospital, Jacksonville, Florida September, 1987
706. The new pharmacology of antiarrhythmic drugs Cardiology Grand Rounds, Tampa General Hospital, Tampa, Florida September, 1987
707. Treatment of ventricular arrhythmia after MI Northwestern University Symposium, Chicago, Illinois August, 1987
708. Problems in antiarrhythmic drug therapy A Roundtable discussion. Jackson Hole, Wyoming August, 1987
709. Arrhythmias associated with ischemic heart disease: Prevention and prognosis Symposium participant, Denver, Colorado August, 1987
710. Medical management of ventricular arrhythmia Staff Conference, Long Island Jewish Medical Center, New York, New York, June, 1987
711. Medical management of supraventricular tachycardia Cardiology Grand Rounds, Millard Fillmore Hospital, Buffalo, New York, June, 1987
712. Risks of antiarrhythmic drug management Symposium participant, Detroit, Michigan June, 1987
713. Management of ventricular arrhythmia in the post-MI patient Symposium participant, Miami, Florida May, 1987
714. Clinical Management of ventricular arrhythmia Cardiology Grand Rounds. New York Medical College, Valhalla, New York May, 1987
715. Nitrous oxide anesthesia for management of ischemic chest discomfort: Role of beta-endorphins National Scientific Session of the American Federation for Clinical Research, San Diego, California May, 1987
716. Implantable devices for ventricular arrhythmia Episcopal Hospital Symposium, Philadelphia, Pennsylvania May, 1987
717. Investigational drugs and devices for cardiac arrhythmia therapy American Heart Association Symposium, Tidewater Chapter, Virginia Beach, Virginia May, 1987
718. Arrhythmias in patients with hypertrophic heart disease Symposium participant, Detroit, Michigan April, 1987
719. Electrophysiology of beta-blockers Symposium participant, Lake Tahoe, Nevada April, 1987
720. Management of patients with supraventricular tachycardia Meet-the-Professor. National Session of the American College of Physicians, New Orleans, Louisiana April, 1987
721. Contemporary management of ventricular arrhythmias Staff Conference, Diagnostic Clinic, Largo, Florida March, 1987
722. Newer antiarrhythmic drugs in the management of patients with malignant ventricular arrhythmia Knoll Symposium, Puerto Plata, Dominican Republic February, 1987
723. Electrophysiology of beta-blockers Symposium participant, San Juan, Puerto Rico December, 1986
724. Stress and cardiovascular disease Symposium Chairman, Atlantic City, New Jersey December, 1986
725. New directions in antiarrhythmic drug development Visiting Scientist, Wyeth Laboratories, Radnor, Pennsylvania December, 1986
726. Therapy of malignant ventricular arrhythmias guided by noninvasive testing University of Virginia Symposium, Coronado, California November, 1986
727. New treatment methods in hypertension Symposium Chairman, Pocono Manor, Mt. Pocono, Pennsylvania October, 1986
728. Thromboxane inhibition and ventricular vulnerability National Scientific Session of the American College of Clinical Pharmacology, Philadelphia, Pennsylvania October, 1986
729. Electrophysiological effects of prostaglandins Eastern Section of the American Federation for Clinical Research, New York City, New York October, 1986
730. Issues in acute cardiac care Symposium Co-Chairman. Atlantic City, New Jersey September, 1986
731. Pulmonary toxicity with amiodarone National Scientific Sessions, American College of Chest Physicians, San Francisco, California September, 1986
732. Modern-day therapy of angina pectoris Cardiology Grand Rounds, Deborah Hospital, Browns Mills, New Jersey September, 1986
733. Post-infarction arrhythmia management Medical Grand Rounds, Southern Ocean City Hospital, Manahawkin, New Jersey September, 1986
734. Contemporary thinking in the treatment of ventricular arrhythmia Medical Grand Rounds, Virginia Beach General Hospital, Virginia Beach, Virginia September, 1986
735. Pacemaker therapy. Medical Knowledge Self-Assessment Program American College of Physicians, Philadelphia, Pennsylvania August, 1986
736. Device therapy for malignant ventricular arrhythmias A Case Study Workshop, Lake Placid, New York August, 1986
737. Calcium blockers in contemporary medical practice Uniontown Hospital, Pittsburgh, Pennsylvania August, 1986
738. Beta-blockers in management of supraventricular tachycardia Symposium, Denver, Colorado July, 1986
739. Applications and limitations of invasive and noninvasive testing A Case Study Workshop, Montauk, Long Island, New York May, 1986
740. Invasive vs. noninvasive evaluation of ventricular arrhythmias A Case Study Workshop, Williamsburg, Virginia May, 1986
741. Pharmaceutical development of antiarrhythmic drugs Visiting Scientist, Upjohn Company, Kalamazoo, Michigan May, 1986
742. Products of the arachidonic acid pathway and vulnerability to ventricular fibrillation National Scientific Sessions of the American Federation for Clinical Research, Washington, D.C May, 1986
743. New concepts in the development of antiarrhythmic drugs: Focus on Class III agents Visiting Scientist, Wyeth Laboratories, Radnor, Pennsylvania April, 1986
744. Acute intravenous amiodarone: Mechanism of its antiarrhythmic effect. National Scientific Sessions of the American College of Cardiology, Atlanta, Georgia March, 1986
745. Cardiac electrophysiology and mechanisms of arrhythmia Symposium participant, Atlanta, Georgia February, 1986
746. Beta-adrenergic blockade for the prevention of sudden death Medical Grand Rounds, University of Kansas Medical Center, Kansas City, Kansas January, 1986
747. Medical management of coronary disease Symposium participant, Cleveland, Ohio December, 1985
748. Effect of calcium-additives on incidence of ventricular arrhythmia during coronary angiography National Scientific Sessions of the American Heart Association, Washington, D.C., November, 1985
749. Medical management of angina pectoris Symposium participant, Cleveland, Ohio November, 1985
750. Beta-blockade for arrhythmias induced in an acute and chronic feline infarction model National Scientific Sessions of the American College of Chest Physicians, New Orleans, Louisiana October, 1985
751. Guidelines for investigation and approval of new antiarrhythmic drugs FDA Symposium, Philadelphia, Pennsylvania October, 1985
752. Effect of calcium channel blockade on intra-atrial reentry tachycardia Eastern Section Meeting of the American Federation for Clinical Research, Baltimore, Maryland September, 1985
753. Treatment of malignant arrhythmias in the critically ill Symposium, Florida Society of Critical Care Medicine, Marco Island, Florida August, 1985
754. Effect of BW 755C on vulnerability to ventricular fibrillation in the cat . American Society of Pharmacology and Experimental Therapeutics, Boston, Massachusetts August, 1985
755. Management of patients with acute myocardial infarction Symposium, Eastern Virginia Medical School, Norfolk, Virginia July, 1985
756. Modern therapy of angina pectoris Medical Grand Rounds, Putnam Medical Center, Carmel, New York June, 1985
757. Antiarrhythmic drugs for treatment of ventricular fibrillation Cardiovascular Research Conferences. New England Deaconess Hospital, Boston, Massachusetts June, 1985
758. Medical management of the sudden death survivor Medical Grand Rounds, Atlantic City Medical Center, Atlantic City, New Jersey May, 1985
759. New perspectives in the management of malignant ventricular arrhythmias Cardiology Grand Rounds, Buffalo General Hospital, Buffalo, New York, May, 1985
760. Nadolol for refractory supraventricular tachycardia North American Society for Pacing and Electrophysiology, Toronto, Canada May, 1985
761. Effect of leukotriene blockade on vulnerability to ventricular fibrillation National Scientific Sessions of the American Federation for Clinical Research, Washington, D.C., May, 1985
762. Cardiology for specialists and referring physicians Program Director, Host Farms, Lancaster, Pennsylvania April, 1985
763. Ventricular arrhythmia and acute infarction Cardiology Grand Rounds, Boston University Hospital, Boston, Massachusetts April, 1985
764. Out-of-hospital sudden death prevention Medical Staff Conference, Helene Fuld Medical Center, Trenton, New Jersey April, 1985
765. Management of malignant ventricular arrhythmias Medical Grand Rounds, Wilmington Medical Center, Wilmington, Delaware March, 1985
766. Diagnosis and management of supraventricular tachycardia Medical Grand Rounds, Milton S. Hershey Medical Center of Pennsylvania State University, Hershey, Pennsylvania, March, 1985
767. Management of patients with sudden cardiac death Medical Staff Conference, Bebe Hospital, Rehoboth Beach, Delaware February, 1985
768. Out-of-hospital sudden death Medical Grand Rounds, Metropolitan Hospital, Philadelphia, Pennsylvania February, 1985
769. Beta-blocker therapy for the prevention of sudden cardiac death. Medical Staff Grand Rounds, Riverview Hospital, Red Bank, New Jersey January, 1985
770. Medical management of cardiac arrhythmias Medical Grand Rounds, St. Michael's Medical Center, Newark, New Jersey December, 1984
771. Issues in the prevention of sudden death Medical Grand Rounds, Nanacock Memorial Hospital, Seaford, Delaware December, 1984
772. Post-MI management and the use of beta-blockers Delaware State Osteopathic Medical Society, Wilmington, Delaware November, 1984
773. Effect of pacing-induced angina on inducibility of ventricular arrhythmia during programmed electrical stimulation National Scientific Sessions of the American Heart Association, Miami, Florida November, 1984
774. Electrophysiologic consequences of left ventricular hypertrophy Medical Grand Rounds, Princeton Hospital, Princeton, New Jersey October, 1984
775. New antiarrhythmic drugs Medical Grand Rounds, Millard Fillmore Hospital, Buffalo, New York October, 1984
776. Class III antiarrhythmic drugs Annual Scientific Meetings of the American Society of Clinical Pharmacology, Philadelphia, Pennsylvania October, 1984
777. Effect of site of overdrive pacing on dispersion of ventricular refractoriness Eastern Section Meeting of The American Federation for Clinical Research. Philadelphia, Pennsylvania October, 1984
778. The chronic feline infarction model National Scientific Sessions of the American College of Chest Physicians, Dallas, Texas October, 1984
779. Modern medical management of the patient with angina pectoris Medical Grand Rounds, Pocono Hospital, East Stroudsburg, Pennsylvania September, 1984
780. New antiarrhythmic drugs Cardiology Clinical Conference, St. Luke's Roosevelt Medical Center, New York, New York September, 1984
781. Class III antiarrhythmic drugs for treatment of malignant ventricular arrhythmia Medical Grand Rounds, Jersey City Medical Center, Jersey City, New Jersey September, 1984
782. Class III antiarrhythmic drugs in clinical practice Cardiology Grand Rounds, Albert Einstein College of Medicine, New York, New York, September, 1984
783. Mechanism of action of Class III drugs American Section Scientific Meeting of the International Society for Heart Research, Oklahoma City, Oklahoma September, 1984
784. Pacemaker therapy for cardiac arrhythmia Medical Grand Rounds, University of California Irvine Orange, California August, 1984
785. New antiarrhythmic therapy Medical Grand Rounds, Pottsville Hospital and Warne Clinic, Pottsville, Pennsylvania July, 1984
786. Effect of site of stimulation on measurement of vulnerability in the normal and ischemic feline heart National Meeting of the American Federation for Clinical Research, Washington, D.C., May, 1984
787. Electrophysiologic testing in patients with hypertrophic obstructive cardiomyopathy National Meeting of the American Federation for Clinical Research, Washington, D.C., May, 1984
788. Non-medical therapy of malignant ventricular arrhythmias Medical Grand Rounds, Ochsner Clinic Foundation, New Orleans, Louisiana April, 1984
789. Bretylium and newer antiarrhythmic drugs Nicholas A. Antonius Memorial Postgraduate Course, Newark, New Jersey April, 1984
790. Torsades de Pointes Medical Grand Rounds, Philadelphia Veterans Administration Hospital, Philadelphia, Pennsylvania April, 1984
791. Electrophysiologic testing in patients with sudden death Medical Grand Rounds, Temple University School of Medicine, Philadelphia, Pennsylvania, April, 1984
792. Changes in refractoriness reflect vulnerability to ventricular fibrillation during and after myocardial infarction in the cat A.N. Richards Symposium, Physiological Society, Philadelphia, Pennsylvania March, 1984
793. Medical therapy of angina pectoris Grand Rounds, Richmond Memorial Hospital. Staten Island, New York February, 1984
794. Modern therapy of angina pectoris Grand Rounds, St. Elizabeth's Hospital, Youngstown, Ohio January, 1984
795. Correlation between dispersion of refractoriness and vulnerability to ventricular fibrillation Eastern Section Meeting of American Federation for Clinical Research, Boston, Massachusetts October, 1983
796. Supplemental yield of alternate protocols for electrophysiologic induction of ventricular arrhythmia Regional Meeting of the American College of Physicians, Pittsburgh, Pennsylvania October, 1983
797. Vulnerability to ventricular fibrillation in patients with clinically manifest ventricular tachycardia National Scientific Sessions of the American College of Cardiology, New Orleans, Louisiana March, 1983
798. Incidence of inducible ventricular arrhythmias in patients with coronary artery disease National Scientific Sessions of the American Heart Association, Dallas, Texas November, 1982
799. Correlation of results of ambulatory monitoring and electrophysiology study Eastern Section Meeting of the American Federation for Clinical Research, Boston, Massachusetts October, 1982
800. What is optimal medical therapy for angina pectoris? Regional Meeting of the American College of Physicians, Hershey, Pennsylvania September, 1982
801. Intravenous nitroglycerin. Central Pennsylvania Heart Association, Harrisburg, Pennsylvania September, 1982
802. Unnecessary pacemaker implants U.S. Senate testimony September, 1982
803. Ventricular vulnerability - Testing in the animal and clinical laboratories Parkland Hospital Research Seminar, Dallas, Texas June, 1982
804. Nitroglycerin-induced baroreceptor sensitization and protection against vulnerability to ventricular fibrillation National Scientific Meetings of the American Heart Association, Dallas, Texas November, 1981
805. The repetitive extrasystole threshold as an index of vulnerability to ventricular fibrillation in patients with coronary disease. Eastern Regional Meeting of the American Federation for Clinical Research, Boston, Massachusetts, October, 1981
806. The effects of nitroglycerin on intracoronary platelet aggregation and ventricular vulnerability during partial coronary stenosis National Scientific Meetings of the American College of Cardiology, San Francisco, California, March, 1981
807. The repetitive extrasystole as an index of vulnerability to ventricular fibrillation during myocardial ischemia National Scientific Meetings of American College of Cardiology, San Francisco, California, March, 1981
808. Diagnosis and treatment of arrhythmias Program Participant, American Medical Association Conference, Philadelphia, Pennsylvania January, 1981
809. Management of ventricular arrhythmias Program Participant, American College of Cardiology conference, Boston, Massachusetts January, 1981
810. Role of platelet activation in exercise-induced malignant ventricular arrhythmia Meetings of the American Heart Association, Miami, Florida November, 1980
811. Use of radionuclide ventriculography for the assessment of changes in myocardial performance induced by disopyramide phosphate National Scientific Meetings of the American Heart Association, Miami, Florida, November, 1980
812. Effect of alpha-adrenergic receptor stimulation on ventricular electrical properties in the normal canine heart National Meetings of the American Physiologic Society, Toronto, Canada October, 1980
813. Atrial fibrillation as a rhythm of choice National Scientific Meetings of the American Heart Association, Anaheim, California November, 1979
814. Pacemaker removal after unnecessary implantation: Clinical experience and analysis of cost Eastern Regional Meetings of the American Federation for Clinical Research, Boston, Massachusetts October, 1979



Site wide Speaking/Presenting-Abstract/Poster at Mtg

Presentation Event Month, Year
CLINICAL TRIALS, GUIDELINES AND REGULATORY ISSUES IN AF ABLATION 19th International AF Symposium - 2014 January, 2014
STROKE PREVENTION IN ATRIAL FIBRILLATION 19th International AF Symposium - 2014 January, 2014
CHALLENGING CASES IN AF MANAGEMENT - ANTIARRHYTHMIC DRUGS, ANTICOAGULATION, AND CLINICAL DECISION MAKING: PANEL AND AUDIENCE DISCUSSION (10 minutes per case) 19th International AF Symposium - 2014 January, 2014
Panel and Audience Discussion 17th Annual International Atrial Fibrillation Symposium January, 2012
Antiarrhythmic Use in Clinical Practice: Focus on Clinical Trials of Dronedarone 17th Annual International Atrial Fibrillation Symposium January, 2012

4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.